Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
13 "Sunghwan Suh"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Response
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study (Diabetes Metab J 2021;45:675-83)
Jun Sung Moon, Sunghwan Suh, Sang Soo Kim, Heung Yong Jin
Diabetes Metab J. 2022;46(1):162-163.   Published online January 27, 2022
DOI: https://doi.org/10.4093/dmj.2021.0331
  • 3,404 View
  • 137 Download
PDFPubReader   ePub   
Original Articles
Drug/Regimen
Article image
Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
Ji Cheol Bae, Soo Heon Kwak, Hyun Jin Kim, Sang-Yong Kim, You-Cheol Hwang, Sunghwan Suh, Bok Jin Hyun, Ji Eun Cha, Jong Chul Won, Jae Hyeon Kim
Diabetes Metab J. 2022;46(1):81-92.   Published online June 16, 2021
DOI: https://doi.org/10.4093/dmj.2021.0016
  • 8,739 View
  • 451 Download
  • 5 Web of Science
  • 5 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To evaluate the effects of teneligliptin on glycosylated hemoglobin (HbA1c) levels, continuous glucose monitoring (CGM)-derived time in range, and glycemic variability in elderly type 2 diabetes mellitus patients.
Methods
This randomized, double-blinded, placebo-controlled study was conducted in eight centers in Korea (clinical trial registration number: NCT03508323). Sixty-five participants aged ≥65 years, who were treatment-naïve or had been treated with stable doses of metformin, were randomized at a 1:1 ratio to receive 20 mg of teneligliptin (n=35) or placebo (n=30) for 12 weeks. The main endpoints were the changes in HbA1c levels from baseline to week 12, CGM metrics-derived time in range, and glycemic variability.
Results
After 12 weeks, a significant reduction (by 0.84%) in HbA1c levels was observed in the teneligliptin group compared to that in the placebo group (by 0.08%), with a between-group least squares mean difference of –0.76% (95% confidence interval [CI], –1.08 to –0.44). The coefficient of variation, standard deviation, and mean amplitude of glycemic excursion significantly decreased in participants treated with teneligliptin as compared to those in the placebo group. Teneligliptin treatment significantly decreased the time spent above 180 or 250 mg/dL, respectively, without increasing the time spent below 70 mg/dL. The mean percentage of time for which glucose levels remained in the 70 to 180 mg/dL time in range (TIR70–180) at week 12 was 82.0%±16.0% in the teneligliptin group, and placebo-adjusted change in TIR70–180 from baseline was 13.3% (95% CI, 6.0 to 20.6).
Conclusion
Teneligliptin effectively reduced HbA1c levels, time spent above the target range, and glycemic variability, without increasing hypoglycemia in our study population.

Citations

Citations to this article as recorded by  
  • Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study
    Harmanjit Singh, Ravi Rohilla, Shivani Jaswal, Mandeep Singla
    Expert Review of Endocrinology & Metabolism.2024; 19(1): 81.     CrossRef
  • Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects
    Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh, Farideh Javid
    Expert Review of Clinical Pharmacology.2023; 16(1): 49.     CrossRef
  • Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights
    Michelangelo Bauwelz Gonzatti, José Edvar Monteiro Júnior, Antônio José Rocha, Jonathas Sales de Oliveira, Antônio José de Jesus Evangelista, Fátima Morgana Pio Fonseca, Vânia Marilande Ceccatto, Ariclécio Cunha de Oliveira, José Ednésio da Cruz Freire
    Advances in Medical Sciences.2023; 68(2): 402.     CrossRef
  • A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study)
    Banshi Saboo, Suhas Erande, A.G. Unnikrishnan
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2022; 16(2): 102394.     CrossRef
  • Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
    Min Jeong Park, Kyung Mook Choi
    Diabetes & Metabolism Journal.2022; 46(1): 49.     CrossRef
Drug/Regimen
Article image
Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
Jun Sung Moon, Sunghwan Suh, Sang Soo Kim, Heung Yong Jin, Jeong Mi Kim, Min Hee Jang, Kyung Ae Lee, Ju Hyung Lee, Seung Min Chung, Young Sang Lyu, Jin Hwa Kim, Sang Yong Kim, Jung Eun Jang, Tae Nyun Kim, Sung Woo Kim, Eonju Jeon, Nan Hee Cho, Mi-Kyung Kim, Hye Soon Kim, Il Seong Nam-Goong, Eun Sook Kim, Jin Ook Chung, Dong-Hyeok Cho, Chang Won Lee, Young Il Kim, Dong Jin Chung, Kyu Chang Won, In Joo Kim, Tae Sun Park, Duk Kyu Kim, Hosang Shon
Diabetes Metab J. 2021;45(5):675-683.   Published online August 12, 2020
DOI: https://doi.org/10.4093/dmj.2020.0107
  • 36,576 View
  • 387 Download
  • 10 Web of Science
  • 6 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Only few studies have shown the efficacy and safety of glucose-control strategies using the quadruple drug combination. Therefore, the aim of the present study was to investigate the usefulness of the quadruple combination therapy with oral hypoglycemic agents (OHAs) in patients with uncontrolled type 2 diabetes mellitus (T2DM).

Methods

From March 2014 to December 2018, data of patients with T2DM, who were treated with quadruple hypoglycemic medications for over 12 months in 11 hospitals in South Korea, were reviewed retrospectively. We compared glycosylated hemoglobin (HbA1c) levels before and 12 months after quadruple treatment with OHAs. The safety, maintenance rate, and therapeutic patterns after failure of the quadruple therapy were also evaluated.

Results

In total, 357 patients were enrolled for quadruple OHA therapy, and the baseline HbA1c level was 9.0%±1.3% (74.9±14.1 mmol/mol). After 12 months, 270 patients (75.6%) adhered to the quadruple therapy and HbA1c was significantly reduced from 8.9%±1.2% to 7.8%±1.3% (mean change, −1.1%±1.2%; P<0.001). The number of patients with HbA1c <7% increased significantly from 5 to 68 (P<0.005). In addition, lipid profiles and liver enzyme levels were also improved whereas no changes in body weight. There was no significant safety issue in patients treated with quadruple OHA therapy.

Conclusion

This study shows the therapeutic efficacy of the quadruple OHA regimen T2DM and demonstrates that it can be an option for the management of T2DM patients who cannot use insulin or reject injectable therapy.

Citations

Citations to this article as recorded by  
  • Estimating Type 2 Diabetes Prevalence: A Model of Drug Consumption Data
    Rita Oliveira, Matilde Monteiro-Soares, José Pedro Guerreiro, Rúben Pereira, António Teixeira-Rodrigues
    Pharmacy.2024; 12(1): 18.     CrossRef
  • Disease burden and symptom management in type 2 diabetic patients: A phenomenological study
    Sevgi Demir Çam, Sevda Uzun
    Public Health Nursing.2024;[Epub]     CrossRef
  • Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study
    Kyung-Soo Kim, Kyung Ah Han, Tae Nyun Kim, Cheol-Young Park, Jung Hwan Park, Sang Yong Kim, Yong Hyun Kim, Kee Ho Song, Eun Seok Kang, Chul Sik Kim, Gwanpyo Koh, Jun Goo Kang, Mi Kyung Kim, Ji Min Han, Nan Hee Kim, Ji Oh Mok, Jae Hyuk Lee, Soo Lim, Sang S
    Diabetes & Metabolism.2023; 49(4): 101440.     CrossRef
  • Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study
    Minyoung Lee, Woo‐je Lee, Jae Hyeon Kim, Byung‐Wan Lee
    Diabetes, Obesity and Metabolism.2022; 24(6): 1105.     CrossRef
  • A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
    Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
    Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
  • Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
    Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
    Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
Review
Complications
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Sunghwan Suh, Kwang-Won Kim
Diabetes Metab J. 2019;43(6):733-743.   Published online December 23, 2019
DOI: https://doi.org/10.4093/dmj.2019.0177
  • 9,897 View
  • 279 Download
  • 100 Web of Science
  • 107 Crossref
AbstractAbstract PDFPubReader   

Cancer incidence appears to be increased in both type 1 and type 2 diabetes mellitus (DM). DM represents a risk factor for cancer, particularly hepatocellular, hepatobiliary, pancreas, breast, ovarian, endometrial, and gastrointestinal cancers. In addition, there is evidence showing that DM is associated with increased cancer mortality. Common risk factors such as age, obesity, physical inactivity and smoking may contribute to increased cancer risk in patients with DM. Although the mechanistic process that may link diabetes to cancer is not completely understood yet, biological mechanisms linking DM and cancer are hyperglycemia, hyperinsulinemia, increased bioactivity of insulin-like growth factor 1, oxidative stress, dysregulations of sex hormones, and chronic inflammation. However, cancer screening rate is significantly lower in people with DM than that in people without diabetes. Evidence from previous studies suggests that some medications used to treat DM are associated with either increased or reduced risk of cancer. However, there is no strong evidence supporting the association between the use of anti-hyperglycemic medication and specific cancer. In conclusion, all patients with DM should be undergo recommended age- and sex appropriate cancer screenings to promote primary prevention and early detection. Furthermore, cancer should be screened in routine diabetes assessment.

Citations

Citations to this article as recorded by  
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2024
    Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Laya Ekhlaspour, Talya K. Fleming, Marisa E. Hilliard, Eric L. Johnson, Kamlesh Khunti, Ildiko Lingvay, Glenn Matfin, Rozalina G. McCoy, Nicola Napoli
    Diabetes Care.2024; 47(Supplement): S52.     CrossRef
  • Editorial: The relationship between diabetes and cancers and its underlying mechanisms, volume II
    Qiang Huo, Shuo Wang, Ying Hou, Reginald M. Gorczynski, Yining Shen, Bin Wang, Hanyi Ge, Tao Li
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Factors associated with gastric and duodenal neuroendocrine tumors: A multicenter case-control study
    Kwangwoo Nam, Su Youn Nam, Jun Chul Park, Young Sin Cho, Hyuk Soon Choi, Kyoungwon Jung, Seon-Young Park, Joon Hyun Cho, Hyonho Chun
    Digestive and Liver Disease.2024; 56(9): 1592.     CrossRef
  • Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With and Without Type 2 Diabetes
    Yunus GÜR, Egemen TURAL, Akın DAYAN
    Konuralp Tıp Dergisi.2024; 16(1): 26.     CrossRef
  • Prognostic significance of glucose‐lipid metabolic index in pancreatic cancer patients with diabetes mellitus
    Hailiang Wang, Shiye Ruan, Zelong Wu, Qian Yan, Yubin Chen, Jinwei Cui, Zhongyan Zhang, Shanzhou Huang, Baohua Hou, Chuanzhao Zhang
    Cancer Medicine.2024;[Epub]     CrossRef
  • Preoperative glucose-to-lymphocyte ratio predicts survival in cancer
    Le Liu, Bei-bei Zhang, Yuan-zhou Li, Wen-juan Huang, Ye Niu, Qing-chun Jia, Wen Wang, Jia-rui Yuan, Shi-di Miao, Rui-tao Wang, Guang-yu Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Higher Prevalence of Cancer in Patients with Diabetic Foot Syndrome
    Chiara Goretti, Alessandro Prete, Alex Brocchi, Elisabetta Iacopi, Letizia Pieruzzi, Alberto Piaggesi
    Journal of Clinical Medicine.2024; 13(5): 1448.     CrossRef
  • Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment
    Ling-Hsiang Chuang, Huanlan Zhang, Tianqi Hong, Shitong Xie
    The Patient - Patient-Centered Outcomes Research.2024; 17(5): 565.     CrossRef
  • Diabetes and the social, biologic, and behavioral determinants of endometrial cancer in the United States
    Nour Massouh, Ayad A. Jaffa, Miran A. Jaffa
    BMC Cancer.2024;[Epub]     CrossRef
  • Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
    O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, S. A. Berns, A. V. Budnevsky, V. V. Gainitdinova, A. A. Garanin, V. M. Gorbunov, A. Yu.
    Cardiovascular Therapy and Prevention.2024; 23(3): 3696.     CrossRef
  • Association between glycemic status and the risk of gastric cancer in pre/peri-and postmenopausal women: A nationwide cohort study
    Kyung Hee Han, Yoon Jin Choi, Tae Il Kim, Noh Hyun Park, Kyung-do Han, Dong Ho Lee
    Annals of Epidemiology.2024; 94: 106.     CrossRef
  • Severity of Complications and Duration of Type 2 Diabetes and the Risk of Cancer: A Population-Based Study
    Yu-Wen Hu, Chiu-Mei Yeh, Chia-Jen Liu, Tzeng-Ji Chen, Nicole Huang, Yiing-Jenq Chou
    Cancer Epidemiology, Biomarkers & Prevention.2024; 33(5): 739.     CrossRef
  • Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1)
    Zsolt Abonyi-Tóth, György Rokszin, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő A. Molnár, Gábor Sütő
    Cancers.2024; 16(9): 1745.     CrossRef
  • Diabetes and obesity: the role of stress in the development of cancer
    Angelo Avogaro
    Endocrine.2024; 86(1): 48.     CrossRef
  • DIABETES MELLITUS TIPO 2 E OBESIDADE, PRÓGONOS DE NEOPLASIAS?
    Victor Becchi, Luísa Emanoela Bandolin Goinski, Ana Letícia Loesch Wojcik, Patrícia Costa Mincoff Barbanti
    Revista Contemporânea.2024; 4(7): e5071.     CrossRef
  • The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study
    Niels A. D. Guchelaar, Stefan A. J. Buck, Leni van Doorn, Koen G. A. M. Hussaarts, Yorick Sandberg, Annemieke van der Padt-Pruijsten, Robbert J. van Alphen, Laura Poppe-Manenschijn, Isolde Vleut, Peter de Bruijn, Roelof W. F. van Leeuwen, Bianca Mostert,
    Clinical Pharmacokinetics.2024; 63(7): 1037.     CrossRef
  • Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
    Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, Jafar Fallahi
    European Journal of Pharmacology.2024; 978: 176803.     CrossRef
  • Associations between Diabetes Mellitus and Selected Cancers
    Monika Pliszka, Leszek Szablewski
    International Journal of Molecular Sciences.2024; 25(13): 7476.     CrossRef
  • Exploring the Interplay of Diabetes, Deaf Patient Reported Outcomes, and Cancer Screening in Deaf and Hard of Hearing Women
    Emmanuel Perrodin-Njoku, Sowmya Rao, Regina Wang, Christopher Moreland, Poorna Kushalnagar
    International Journal of Women's Health.2024; Volume 16: 1235.     CrossRef
  • Causal relationship between type 2 diabetes and glioblastoma: bidirectional Mendelian randomization analysis
    Wei Chen, Taoyuan Zhang, Hui Zhang
    Scientific Reports.2024;[Epub]     CrossRef
  • Findings on Age at Onset of Cancer in Diabetic and Non-diabetic Populations
    Ángel Gómez-Villanueva, Sharon I Martínez-Gómez, David E González-Mendoza, Edgar A Ramos-Gutiérrez, Roosvelth G Hernández-Ramírez, Lesly D Delgado-Villarejo, José J Garduño-García
    Cureus.2024;[Epub]     CrossRef
  • Association between prediabetes and the incidence of gastric cancer: A meta-analysis
    Shenggang Wang, Jiamin Zhao, Chong Liu
    Medicine.2024; 103(34): e39411.     CrossRef
  • Lifestyle and metabolic factors affect risk for meningioma in women: a prospective population-based study (The Cohort of Norway)
    Anamaria Gheorghiu, Cathrine Brunborg, Tom B. Johannesen, Eirik Helseth, John-Anker Zwart, Markus K. H. Wiedmann
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Casual effects of type 1 diabetes mellitus on site-specific digestive cancers: a Mendelian randomisation analysis
    Jinli Zhao, Wenjin Li, Libo Chen, Mingyong Li, Weiming Deng
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Changes in serum uteroglobin level in type 2 diabetes mellitus patients
    Joung Youl Lim, Sang-Hyeon Ju, Ji Min Kim, Hyon-Seung Yi, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku, Kyong Hye Joung
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Continuum of type 2 diabetes mellitus and its comorbidity with other somatic diseases
    M.N. Mamedov, I.V. Druk, G.G. Arabidze, Kh.R. Akhundova
    Russian Journal of Preventive Medicine.2024; 27(9): 123.     CrossRef
  • The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights
    Abutaleb Asiri, Ali Al Qarni, Ahmed Bakillah
    Diagnostics.2024; 14(19): 2132.     CrossRef
  • Patterns and Trends in Mortality Associated With and Due to Diabetes Mellitus in a Transitioning Region With 3.17 Million People: Observational Study
    Xiaopan Li, Ru Liu, Yichen Chen, Yan Han, Qizhe Wang, Yaxin Xu, Jing Zhou, Sunfang Jiang
    JMIR Public Health and Surveillance.2023; 9: e43687.     CrossRef
  • Diabetes and cancer: Optimising glycaemic control
    Nalinie Joharatnam‐Hogan, Daniel L. Morganstein
    Journal of Human Nutrition and Dietetics.2023; 36(2): 504.     CrossRef
  • Need for improving immunization status and preventive care in diabetes mellitus patients
    Teresa Gisinger, Alexandra Kautzky-Willer, Michael Leutner
    Wiener klinische Wochenschrift.2023; 135(13-14): 336.     CrossRef
  • Impact of cumulative hyperglycemic burden on the pancreatic cancer risk: A nationwide cohort study
    Dong-Hoe Koo, Kyungdo Han, Cheol-Young Park
    Diabetes Research and Clinical Practice.2023; 195: 110208.     CrossRef
  • Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
    Zhihong Yue, Lin Pei, Guangyan Meng, Aimin Zhang, Meng Li, Mei Jia, Hui Wang, Linlin Cao
    Metabolites.2023; 13(1): 90.     CrossRef
  • Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis
    Margaret A. Heller, Sarah C. Nyirjesy, Robert Balsiger, Nicholas Talbot, Kyle K. VanKoevering, Catherine T. Haring, Matthew O. Old, Stephen Y. Kang, Nolan B. Seim
    Oral Oncology.2023; 137: 106300.     CrossRef
  • Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
    Alessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, Francesco Perri, Marco Cascella, Francesco Sabbatino, Maurizio Capuozzo, Vincenza Granata, Silvia Zappavigna, Angela Lombardi, Marianna Scrima, Nadia Petrillo, Monica Ianniello, Marika Casillo,
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • The relationship between the CUN-BAE body fatness index and incident diabetes: a longitudinal retrospective study
    Qing Peng, Zihao Feng, Zhuojian Cai, Dixing Liu, Jiana Zhong, Hejia Zhao, Xiuwei Zhang, Weikun Chen
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Association of four lipid-derived indicators with the risk of developing type 2 diabetes: a Chinese population-based cohort study
    Linfeng He, Wenbin Zheng, Zeyu Li, Wen Kong, Tianshu Zeng
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Screening for Coronary Artery Disease in Cancer Survivors
    Ragani Velusamy, Mark Nolan, Andrew Murphy, Paaladinesh Thavendiranathan, Thomas H. Marwick
    JACC: CardioOncology.2023; 5(1): 22.     CrossRef
  • Diabetes mellitus induces a novel inflammatory network involving cancer progression: Insights from bioinformatic analysis and in vitro validation
    Yejun Tan, Jin Kang, Hongli Li, Aifang Zhong, Yaqiong Liu, Zheyu Zhang, Roujie Huang, Xin Cheng, Weijun Peng
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • Increased Breast and Colorectal Cancer Risk in Type 2 Diabetes: Awareness Among Adults With and Without Diabetes and Information Provision on Diabetes Websites
    Laura Ashley, Kathryn A Robb, Daryl B O’Connor, Rebecca Platt, Mollie Price, Olivia Robinson, Elizabeth Travis, Lorraine Lipscombe, Ramzi Ajjan, Rebecca Birch
    Annals of Behavioral Medicine.2023; 57(5): 386.     CrossRef
  • Primary peritoneal serous psammocarcinoma, rare variant: A case report
    Srujan Kancharla, Anne Alaniz, Pulin Kothari, Stacy Norton
    Gynecologic Oncology Reports.2023; 47: 101176.     CrossRef
  • Association between the Finnish Diabetes Risk Score and cancer in middle-aged and older adults: Involvement of inflammation
    Yu Peng, Peng Wang, Jianxiao Gong, Fubin Liu, Yating Qiao, Changyu Si, Xixuan Wang, Huijun Zhou, Fangfang Song
    Metabolism.2023; 144: 155586.     CrossRef
  • Interlinking of diabetes mellitus and cancer: An overview
    Iftikhar Ahmad, Mohd Suhail, Ausaf Ahmad, Mahmoud Alhosin, Shams Tabrez
    Cell Biochemistry and Function.2023; 41(5): 506.     CrossRef
  • High glucose promotes the progression of colorectal cancer by activating the BMP4 signaling and inhibited by glucagon-like peptide-1 receptor agonist
    Bingwei Ma, Xingchun Wang, Hui Ren, Yingying Li, Haijiao Zhang, Muqing Yang, Jiyu Li
    BMC Cancer.2023;[Epub]     CrossRef
  • Diabetes mellitus and the female reproductive system tumors
    K. I. Sharafutdinova, V. S. Shlyapina, A. I. Baeva, A. A. Timurshin, I. E. Sabanaeva, A. G. Nakieva, M. F. Kalashnikova, M. N. Khabibov
    Problems of Endocrinology.2023; 69(3): 103.     CrossRef
  • Global estimates of rehabilitation needs and disease burden in tracheal, bronchus, and lung cancer from 1990 to 2019 and projections to 2045 based on the global burden of disease study 2019
    Xigui Lai, Conghui Li, Yao Yang, Mingyuan Niu, Yujie Yang, Shanshan Gu, Weiqian Hou, Lili Chen, Yi Zhu
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Social and racial inequalities in diabetes and cancer in the United States
    Nour Massouh, Ayad A. Jaffa, Hani Tamim, Miran A. Jaffa
    Frontiers in Public Health.2023;[Epub]     CrossRef
  • Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data
    Veronika Ruzsányi, Miklós Péter Kalapos
    Journal of Breath Research.2023; 17(4): 044001.     CrossRef
  • The impact of diabetes status on total and site-specific cancer risk in the elderly population: A nationwide cohort study
    Kyuho Kim, Bongseong Kim, Hyunho Kim, Hyung Soon Park, Yu-Bae Ahn, Seung-Hyun Ko, Kyungdo Han, Jae-Seung Yun
    Diabetes Research and Clinical Practice.2023; 203: 110866.     CrossRef
  • Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
    Ziyue Zhu, Samuel Yeung Shan Wong, Joseph Jao Yiu Sung, Thomas Yuen Tung Lam
    Current Diabetes Reports.2023; 23(10): 253.     CrossRef
  • PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus
    Qing Wu, Xingxing Du, Jianing Cheng, Xiuying Qi, Huan Liu, Xiaohong Lv, Xieyang Gong, Changxin Shao, Muhong Wang, Luxiao Yue, Xin Yang, Shiyu Li, Yafang Zhang, Xuemei Li, Huike Yang
    Cell Communication and Signaling.2023;[Epub]     CrossRef
  • Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice
    Sabry M. Attia, Sheikh F. Ahmad, Ahmed Nadeem, Mohamed S.M. Attia, Mushtaq A. Ansari, Abdelkader E. Ashour, Norah A. Albekairi, Mohammed A. Al-Hamamah, Ali A. Alshamrani, Saleh A. Bakheet
    Mutation Research/Genetic Toxicology and Environmental Mutagenesis.2023; 892: 503707.     CrossRef
  • Analysis of differential membrane proteins related to matrix stiffness-mediated metformin resistance in hepatocellular carcinoma cells
    Xiangyu Gao, Jiali Qian, Yang Zhang, Heming Wang, Jiefeng Cui, Yehong Yang
    Proteome Science.2023;[Epub]     CrossRef
  • Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study
    Mia Scholten, Anders Halling, Kathleen Bennett
    PLOS ONE.2023; 18(10): e0292853.     CrossRef
  • The interplay between antidiabetic medications and cancer risk
    Duaa Durrani, Muhammad Hassan, Aimen Zulfikar
    International Journal of Scientific Reports.2023; 9(11): 384.     CrossRef
  • Causal association between inflammatory bowel disease and 32 site-specific extracolonic cancers: a Mendelian randomization study
    Hui Gao, Shuhao Zheng, Xin Yuan, Jiarong Xie, Lei Xu
    BMC Medicine.2023;[Epub]     CrossRef
  • Association between diabetes at different diagnostic ages and risk of cancer incidence and mortality: a cohort study
    Yu Peng, Fubin Liu, Peng Wang, Yating Qiao, Changyu Si, Xixuan Wang, Jianxiao Gong, Huijun Zhou, Fengju Song, Fangfang Song
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • The Characteristics and Risk of Mortality in the Elderly Korean Population
    Sunghwan Suh
    Endocrinology and Metabolism.2023; 38(5): 522.     CrossRef
  • Clinical potentials of metformin in cancer therapy
    Nidhi Sharma, Richa Dhingra
    Journal of Diabetology.2023; 14(4): 186.     CrossRef
  • High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus
    Charupong Saengboonmee, Marutpong Detarya, Sakkarn Sangkhamanon, Kanlayanee Sawanyawisuth, Wunchana Seubwai, Sopit Wongkham
    Nutrition and Cancer.2022; 74(5): 1734.     CrossRef
  • Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries
    Christoph Roderburg, Sven H. Loosen, Laura Hoyer, Tom Luedde, Karel Kostev
    Journal of Cancer Research and Clinical Oncology.2022; 148(5): 1057.     CrossRef
  • Metformin and survival: Is there benefit in a cohort limited to diabetic women with endometrial, breast, or ovarian cancer?
    Lara S. Lemon, Brian Orr, Francesmary Modugno, Ronald J. Buckanovich, Lan Coffman, Robert P. Edwards, Sarah Taylor
    Gynecologic Oncology.2022; 165(1): 60.     CrossRef
  • The Relationship Between Diabetes Mellitus and Cancers and Its Underlying Mechanisms
    Bing Zhu, Shen Qu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The impact of diabetes mellitus on levels of sex hormones and their receptors in tumor tissues in female rats with Guerin’s carcinoma
    E. M. Frantsiyants, V. A. Bandovkina, I. V. Kaplieva, E. I. Surikova, Yu. A. Pogorelova, N. D. Cheryarina, I. M. Kotieva, M. I. Morozova, A. I. Shikhlyarova
    Research and Practical Medicine Journal.2022; 9(1): 23.     CrossRef
  • Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study
    Oh. Hyeong Lee, Yong-Moon Park, Seung-Hyun Ko, Kyuna Lee, Yeonji Kim, Kyungdo Han, Jung-Hae Cho
    BMC Cancer.2022;[Epub]     CrossRef
  • Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study
    Jing Ding, Xudong Li, Jun Ge, Yuanqian Gong, Ya Zhou, Juan Xiao, Qin Yang, Jing Chen, Mian Mao
    Cancer Management and Research.2022; Volume 14: 1313.     CrossRef
  • The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients
    Xi-yu Liu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1113.     CrossRef
  • Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
    Christian Jenssen, Cristine Pietsch
    Die Diabetologie.2022; 18(4): 379.     CrossRef
  • Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
    Guotai Sheng, Dingyang Liu, Maobin Kuang, Yanjia Zhong, Shuhua Zhang, Yang Zou
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1677.     CrossRef
  • The Association of Dietary Fiber Intake in Three Meals with All-Cause and Disease-Specific Mortality among Adults: The U.S. National Health and Nutrition Examination Survey, 2003–2014
    Jiayue Qi, Jian Gao, Yuntao Zhang, Wanying Hou, Tianshu Han, Changhao Sun
    Nutrients.2022; 14(12): 2521.     CrossRef
  • A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
    Lin-Lin Cao, Yi Han, Lin Pei, Zhi-Hong Yue, Bo-Yu Liu, Jing-Wen Cui, Mei Jia, Hui Wang
    Metabolites.2022; 12(7): 610.     CrossRef
  • Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
    Eun-Jung Rhee
    Endocrinology and Metabolism.2022; 37(3): 415.     CrossRef
  • Improvement in Age at Mortality and Changes in Causes of Death in the Population with Diabetes: An Analysis of Data from the Korean National Health Insurance and Statistical Information Service, 2006 to 2018
    Eugene Han, Sun Ok Song, Hye Soon Kim, Kang Ju Son, Sun Ha Jee, Bong-Soo Cha, Byung-Wan Lee
    Endocrinology and Metabolism.2022; 37(3): 466.     CrossRef
  • Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract
    Piero Portincasa, Leonilde Bonfrate, David Q.‐H. Wang, Gema Frühbeck, Gabriella Garruti, Agostino Di Ciaula
    European Journal of Clinical Investigation.2022;[Epub]     CrossRef
  • Editorial: The relationship between diabetes and cancers and its underlying mechanisms
    Qiang Huo, Jing Wang, Nannan Zhang, Long Xie, Heshan Yu, Tao Li
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Oxidatively Damaged Nucleic Acid: Linking Diabetes and Cancer
    Xiujuan Hong, Yiqiu Hu, Zhijun Yuan, Zhihao Fang, Xiaoxiao Zhang, Ying Yuan, Cheng Guo
    Antioxidants & Redox Signaling.2022; 37(16-18): 1153.     CrossRef
  • Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links
    Ya Wang, Xinling Zeng, Jie Tan, Yi Xu, Cunjian Yi
    Medicine.2022; 101(34): e30299.     CrossRef
  • The Good, the Bad and the New about Uric Acid in Cancer
    Simone Allegrini, Mercedes Garcia-Gil, Rossana Pesi, Marcella Camici, Maria Grazia Tozzi
    Cancers.2022; 14(19): 4959.     CrossRef
  • Family cancer history and smoking habit associated with sarcoma in a Japanese population study
    Yoshihiro Araki, Norio Yamamoto, Yoshikazu Tanzawa, Takahiro Higashi, Aya Kuchiba, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Makoto Endo, Eisuke Kobayashi, Hiroyuki Tsuchiya, Akira Kawai
    Scientific Reports.2022;[Epub]     CrossRef
  • Decreased IGF-1 level is associated with restrained amino acid metabolism in NSCLC with diabetes mellitus
    Hehe Lv, Fan Zhang, Can Liang, Xuekui Liu, Yamei Ma, Jiayi Li, Yan Ye, Shanwen Si, Yaran Liu, Hao Heng, Houfa Geng
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Acute Pancreatitis Increases the Risk of Gastrointestinal Cancer in Type 2 Diabetic Patients: A Korean Nationwide Cohort Study
    Jin Ho Choi, Woo Hyun Paik, Dong Kee Jang, Min Kyu Kim, Ji Kon Ryu, Yong-Tae Kim, Kyungdo Han, Sang Hyub Lee
    Cancers.2022; 14(22): 5696.     CrossRef
  • Targets for the prevention of comorbidity of cardiovascular and cancer diseases
    M. N. Mamedov, K. K. Badeinikova, A. K. Karimov
    Russian Journal of Cardiology.2022; 27(11): 5235.     CrossRef
  • Prevalence and potential risk factors of self-reported diabetes among elderly people in China: A national cross-sectional study of 224,142 adults
    Xing Hu, Lingbing Meng, Zhimin Wei, Hongxuan Xu, Jianyi Li, Yingying Li, Na Jia, Hui Li, Xin Qi, Xuezhai Zeng, Qiuxia Zhang, Juan Li, Deping Liu
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Urinary Exosomal Tissue TIMP and Angiopoietin-1 Are Preoperative Novel Biomarkers of Well-Differentiated Thyroid Cancer
    Chih-Yuan Wang, Shyang-Rong Shih, Kuen-Yuan Chen, Pei-Jie Huang
    Biomedicines.2022; 11(1): 24.     CrossRef
  • Acquired and modifiable cardiovascular risk factors in patients treated for cancer
    Gary S. Beasley, Jeffrey A. Towbin
    Journal of Thrombosis and Thrombolysis.2021; 51(4): 846.     CrossRef
  • Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
    Wamidh H. Talib, Asma Ismail Mahmod, Sara Feras. Abuarab, Eliza Hasen, Amer A. Munaim, Shatha Khaled Haif, Amani Marwan Ayyash, Samar Khater, Intisar Hadi AL-Yasari, Lina T. Al Kury
    Molecules.2021; 26(8): 2179.     CrossRef
  • Epidemiological link between obesity, type 2 diabetes mellitus and cancer
    Cornelius J Fernandez, Annu Susan George, Nikhila A Subrahmanyan, Joseph M Pappachan
    World Journal of Methodology.2021; 11(3): 23.     CrossRef
  • Evaluation of the Efficacy of the Hospital Glycemic Management System for Patients with Malignant Tumors and Hyperglycemia
    Juan Jiang, Danlan Pu, Renzhi Hu, Mingyang Hu, Qinan Wu
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2717.     CrossRef
  • Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
    Aldona Kasprzak
    International Journal of Molecular Sciences.2021; 22(12): 6434.     CrossRef
  • TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
    Desh Deepak Singh, Dharmendra Kumar Yadav
    Biomedicines.2021; 9(8): 876.     CrossRef
  • GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
    Xin Zhao, Minghe Wang, Zhitong Wen, Zhihong Lu, Lijuan Cui, Chao Fu, Huan Xue, Yunfeng Liu, Yi Zhang
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • The Aneugenicity of Ketone Bodies in Colon Epithelial Cells Is Mediated by Microtubule Hyperacetylation and Is Blocked by Resveratrol
    Haruka Sudo, Akira Kubo
    International Journal of Molecular Sciences.2021; 22(17): 9397.     CrossRef
  • EFFECT OF DIABETES MELLITUS ON THE LEVEL OF GROWTH FACTORS IN GUERIN CARCINOMA IN RATS OF BOTH SEXES
    E.M. Frantsiyants, V.A. Bandovkina, I.V. Kaplieva, E.I. Surikova, I.V. Neskubina, L.K. Trepitaki, N.D. Cheryarina, Yu.A. Pogorelova, L.A. Nemashkalova, A.I. Shikhlyarova, I.M. Kotieva, M.I. Morozova
    Ulyanovsk Medico-biological Journal.2021; : 129.     CrossRef
  • Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS
    Miao Liu, Yu Liu, Hua Feng, Yixin Jing, Shuang Zhao, Shujia Yang, Nan Zhang, Shi Jin, Yafei Li, Mingjiao Weng, Xinzhu Xue, Fuya Wang, Yongheng Yang, Xiaoming Jin, Dan Kong
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Diabetes mellitus and cancer: a system of insulin-like growth factors
    E. M. Frantsiyants, E. I. Surikova, I. V. Kaplieva, V. A. Bandovkina, I. V. Neskubina, E. A. Sheiko, M. I. Morozova, I. M. Kotieva
    Problems of Endocrinology.2021; 67(5): 34.     CrossRef
  • Diabetes and Cancer: Risk, Challenges, Management and Outcomes
    Rabia K. Shahid, Shahid Ahmed, Duc Le, Sunil Yadav
    Cancers.2021; 13(22): 5735.     CrossRef
  • Obesity, Diabetes, and Increased Cancer Progression
    Dae-Seok Kim, Philipp E. Scherer
    Diabetes & Metabolism Journal.2021; 45(6): 799.     CrossRef
  • Simple Serum Pancreatic Ductal Adenocarcinoma (PDAC) Protein Biomarkers—Is There Anything in Sight?
    Monika Kapszewicz, Ewa Małecka-Wojciesko
    Journal of Clinical Medicine.2021; 10(22): 5463.     CrossRef
  • Chronic non-communicable diseases, risk factors, and quality of life in patients with malignancies of various localizations
    M.N. Mamedov, V.I. Potievskaya, E.K. Saribekyan, O.V. Pikin, D.V. Sidorov, Z.M. Salimov, V.A. Kutsenko, O.M. Drapkina
    Profilakticheskaya meditsina.2021; 24(11): 45.     CrossRef
  • Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
    Mayu Hosio, Elina Urpilainen, Ari Hautakoski, Mikko Marttila, Martti Arffman, Reijo Sund, Anne Ahtikoski, Ulla Puistola, Peeter Karihtala, Arja Jukkola, Esa Läärä
    Acta Oncologica.2020; 59(9): 1110.     CrossRef
  • Transcriptional Profiling and Biological Pathway(s) Analysis of Type 2 Diabetes Mellitus in a Pakistani Population
    Zarish Noreen, Christopher A. Loffredo, Attya Bhatti, Jyothirmai J. Simhadri, Gail Nunlee-Bland, Thomas Nnanabu, Peter John, Jahangir S. Khan, Somiranjan Ghosh
    International Journal of Environmental Research and Public Health.2020; 17(16): 5866.     CrossRef
  • Screening Strategy of Pancreatic Cancer in Patients with Diabetes Mellitus
    Suguru Mizuno, Yousuke Nakai, Kazunaga Ishigaki, Kei Saito, Hiroki Oyama, Tsuyoshi Hamada, Yukari Suzuki, Akiyuki Inokuma, Sachiko Kanai, Kensaku Noguchi, Tatsuya Sato, Ryunosuke Hakuta, Tomotaka Saito, Naminatsu Takahara, Hirofumi Kogure, Hiroyuki Isayam
    Diagnostics.2020; 10(8): 572.     CrossRef
  • Changes in mortality rates and ratios in people with pharmacologically treated type 2 diabetes mellitus between 2001 and 2016 in Hungary
    György Jermendy, Zoltán Kiss, György Rokszin, Ibolya Fábián, István Wittmann, Péter Kempler
    Diabetes Research and Clinical Practice.2020; 163: 108134.     CrossRef
  • Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target


    Lin Tang, Meng Xu, Long Zhang, Lin Qu, Xiaoyan Liu
    OncoTargets and Therapy.2020; Volume 13: 7411.     CrossRef
  • Arterial stiffness is an independent predictor for risk of mortality in patients with type 2 diabetes mellitus: the REBOUND study
    Jeong Mi Kim, Sang Soo Kim, In Joo Kim, Jong Ho Kim, Bo Hyun Kim, Mi Kyung Kim, Soon Hee Lee, Chang Won Lee, Min Chul Kim, Jun Hyeob Ahn, Jinmi Kim
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • An Overview of Cancer Prevention: Chemoprevention and Immunoprevention
    Kyle J. Gu, Guojun Li
    Journal of Cancer Prevention.2020; 25(3): 127.     CrossRef
  • Type 2 diabetes mellitus facilitates endometrial hyperplasia progression by activating the proliferative function of mucin O-glycosylating enzyme GALNT2
    Xueyan Zhou, Yinxue Xu, Di Yin, Feng Zhao, Zhixiang Hao, Ya’nan Zhong, Jingbo Zhang, Bei Zhang, Xiaoxing Yin
    Biomedicine & Pharmacotherapy.2020; 131: 110764.     CrossRef
  • Diabetes mellitus and the risk of ovarian cancer: a systematic review and meta-analysis of cohort and case–control studies
    Lihai Wang, Lei Zhong, Bin Xu, Min Chen, Hongxiao Huang
    BMJ Open.2020; 10(12): e040137.     CrossRef
Response
Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
Diabetes Metab J. 2015;39(4):350-351.   Published online August 17, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.4.350
  • 3,552 View
  • 31 Download
PDFPubReader   
Review
Glycemic Variability: How Do We Measure It and Why Is It Important?
Sunghwan Suh, Jae Hyeon Kim
Diabetes Metab J. 2015;39(4):273-282.   Published online August 17, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.4.273
  • 20,978 View
  • 612 Download
  • 254 Web of Science
  • 266 Crossref
AbstractAbstract PDFPubReader   

Chronic hyperglycemia is the primary risk factor for the development of complications in diabetes mellitus (DM); however, it is believed that frequent or large glucose fluctuations may independently contribute to diabetes-related complications. Postprandial spikes in blood glucose, as well as hypoglycemic events, are blamed for increased cardiovascular events in DM. Glycemic variability (GV) includes both of these events; hence, minimizing GV can prevent future cardiovascular events. Correcting GV emerges as a target to be pursued in clinical practice to safely reduce the mean blood glucose and to determine its direct effects on vascular complications in diabetes. Modern diabetes management modalities, including glucagon-related peptide-1-based therapy, newer insulins, modern insulin pumps and bariatric surgery, significantly reduce GV. However, defining GV remains a challenge primarily due to the difficulty of measuring it and the lack of consensus regarding the optimal approach for its management. The purpose of this manuscript was not only to review the most recent evidence on GV but also to help readers better understand the available measurement options and how the various definitions relate differently to the development of diabetic complications.

Citations

Citations to this article as recorded by  
  • Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
    Thomas Nyström, Erik Schwarz, Sofia Dahlqvist, Magnus Wijkman, Magnus Ekelund, Helen Holmer, Jan Bolinder, Jarl Hellman, Henrik Imberg, Irl B. Hirsch, Marcus Lind
    Journal of Diabetes Science and Technology.2024; 18(1): 89.     CrossRef
  • Washed microbiota transplantation reduces glycemic variability in unstable diabetes
    Yangyang Li, Qing Liu, Lingyu Zhang, Jing Zou, Rongbo He, Ying Zhou, Chen Qian, Yuxiao Zhu, Rourou Chen, Ying Zhang, Pengpeng Cai, Miao Wang, Wei Shao, Minjun Ji, Hao Wu, Faming Zhang, Zejian Liu, Yu Liu
    Journal of Diabetes.2024;[Epub]     CrossRef
  • Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?
    Yifei Mo, Jingyi Lu, Jian Zhou
    Journal of Diabetes Investigation.2024; 15(1): 5.     CrossRef
  • Statistical Packages and Algorithms for the Analysis of Continuous Glucose Monitoring Data: A Systematic Review
    Mikkel Thor Olsen, Carina Kirstine Klarskov, Arnold Matovu Dungu, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
    Journal of Diabetes Science and Technology.2024;[Epub]     CrossRef
  • Insulin pump treatment vs. multiple daily insulin injections in patients with poorly controlled Type 2 diabetes mellitus: a comparison of cardiovascular effects
    Saverio Tremamunno, Linda Tartaglione, Alessandro Telesca, Alessandro Rizzi, Tamara Felici, Francesco Mazzotta, Antonio De Vita, Emanuele Rizzo, Nello Cambise, Antonietta Belmusto, Dario Pitocco, Gaetano Antonio Lanza
    Endocrine.2024; 84(1): 128.     CrossRef
  • To What Extent Is HbA1c Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study
    Sandra Lazar, Ioana Ionita, Delia Reurean-Pintilei, Romulus Timar, Silvia Ana Luca, Bogdan Timar
    Journal of Clinical Medicine.2024; 13(2): 450.     CrossRef
  • Short-term glycemic variability in non-diabetic, non-obese dogs assessed by common glycemic variability indices
    Tobias Urbanschitz, Lukas Huber, Alexander Tichy, Iwan Anton Burgener, Florian Karl Zeugswetter
    Research in Veterinary Science.2024; 169: 105156.     CrossRef
  • Enhancement of Ambulatory Glucose Profile for Decision Assistance and Treatment Adjustments
    V. K. R. Rajeswari Satuluri, Vijayakumar Ponnusamy
    Diagnostics.2024; 14(4): 436.     CrossRef
  • Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis
    Anna Hjort, David Iggman, Fredrik Rosqvist
    Clinical Nutrition.2024; 43(4): 915.     CrossRef
  • Oral metformin for type-2 diabetes mellitus treatment in a black-tufted marmoset (Callithrix penicillata)
    Janyni Duz, Lívia E. Surita, Letícia Machado, Priscila M.D. Costa, Bruna S. Machado, Stella F. Valle, Marcelo M. Alievi, Álan G. Pöppl
    Pesquisa Veterinária Brasileira.2024;[Epub]     CrossRef
  • A low-glucose eating pattern is associated with improvements in glycemic variability among women at risk for postmenopausal breast cancer: an exploratory analysis
    Michelle R. Jospe, Yue Liao, Erin D. Giles, Barry I. Hudson, Joyce M. Slingerland, Susan M. Schembre
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Glycemic Variability as a Predictor of Graft Failure Following Infrainguinal Bypass for Peripheral Arterial Disease: A Retrospective Cohort Study
    Daniel J. Farndon, Philip C. Bennett, Ian Nunney, Ketan Dhatariya
    Annals of Vascular Surgery.2024; 105: 132.     CrossRef
  • Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
    Juan Gao, Xiujuan Zhou, Hong Gao, Guiping Xu, Chunguang Xie, Hongyan Xie
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • Continuous glucose monitoring in pregnancy
    Ivana Novakovic, Jovana Todorovic, Stefan Dugalic, Maja Macura, Milos Milincic, Miroslava Gojnic
    Srpski arhiv za celokupno lekarstvo.2024; 152(3-4): 214.     CrossRef
  • Vitamin D Deficiency as a Factor Associated with Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
    Valentina Tjandra Dewi, Anak Agung Ayu Putri Laksmidewi, Anak Agung Ayu Suryapraba, Wira Gotera, I Putu Eka Widyadharma, I Made Oka Adnyana
    Siriraj Medical Journal.2024; 76(1): 1.     CrossRef
  • Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale
    Alaa Almagthali, Samiah Alsohimi, Arwa Alkhalaf, Khalid Al Sulaiman, Ohoud Aljuhani
    Scientific Reports.2024;[Epub]     CrossRef
  • Heterogeneity of glycaemic phenotypes in type 1 diabetes
    Guy Fagherazzi, Gloria A. Aguayo, Lu Zhang, Hélène Hanaire, Sylvie Picard, Laura Sablone, Bruno Vergès, Naïma Hamamouche, Bruno Detournay, Michael Joubert, Brigitte Delemer, Isabelle Guilhem, Anne Vambergue, Pierre Gourdy, Samy Hadjadj, Fritz-Line Velayou
    Diabetologia.2024; 67(8): 1567.     CrossRef
  • Incretin therapy in feline diabetes mellitus – A review of the current state of research
    Nina Haller, Thomas A. Lutz
    Domestic Animal Endocrinology.2024; 89: 106869.     CrossRef
  • Yoga as an alternative to cycling in type 1 diabetes: A preliminary study of acute effects on glucose levels
    Antonio Cutruzzolà, Francesca Greco, Martina Parise, Concetta Irace, Agostino Gnasso, Gian Pietro Emerenziani
    Journal of Science and Medicine in Sport.2024; 27(10): 691.     CrossRef
  • Glycemic variability and diabetic cardiac autonomic neuropathy
    A.A. Serhiyenko, T.V. Tsaryk, Y.I. Pavlovskiy, V.A. Serhiyenko
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(4): 225.     CrossRef
  • Short-term glucose prediction in Type 1 Diabetes
    Bogdan-Petru Butunoi, Cristina Stolojescu-Crisan, Viorel Negru
    Procedia Computer Science.2024; 238: 41.     CrossRef
  • Diabetes and Parkinson’s Disease: Understanding Shared Molecular Mechanisms
    Annekatrin König, Tiago F. Outeiro
    Journal of Parkinson's Disease.2024; 14(5): 917.     CrossRef
  • Low- versus High-Glycemic Index Mediterranean-Style Eating Patterns Improved Some Domains of Health-Related Quality of Life but Not Sleep in Adults at Risk for Type 2 Diabetes: The MEDGICarb Randomized Controlled Trial
    Anna Hjort, Robert E Bergia, Marilena Vitale, Giuseppina Costabile, Rosalba Giacco, Gabriele Riccardi, Wayne W Campbell, Rikard Landberg
    The Journal of Nutrition.2024; 154(9): 2743.     CrossRef
  • Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetes
    Ilias Attaye, Julia J. Witjes, Annefleur M. Koopen, Eduard W.J. van der Vossen, Diona Zwirs, Koen Wortelboer, Didier Collard, Elles Marleen Kemper, Maaike Winkelmeijer, Jens J. Holst, Stanley L. Hazen, Folkert Kuipers, Erik S.G. Stroes, Albert K. Groen, W
    iScience.2024; 27(8): 110455.     CrossRef
  • From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring Data
    Simon Lebech Cichosz, Thomas Kronborg, Esben Laugesen, Stine Hangaard, Jesper Fleischer, Troels Krarup Hansen, Morten Hasselstrøm Jensen, Per Løgstrup Poulsen, Peter Vestergaard
    Diabetes Technology & Therapeutics.2024;[Epub]     CrossRef
  • Glycemic Variability and Disordered Eating Among Adolescents and Young Adults with Type 1 Diabetes: The Role of Disinhibited Eating
    Tamar Propper-Lewinsohn, Shlomit Shalitin, Michal Gillon-Keren, Michal Yackobovitch-Gavan, Alon Liberman, Moshe Phillip, Roni Elran-Barak
    Diabetes Technology & Therapeutics.2024;[Epub]     CrossRef
  • The role of Cardiotrophin-1 and echocardiography in early detection of subclinical diabetic cardiomyopathy in children and adolescents with type 1 diabetes mellitus
    Samah A. Hassanein, Mona M. Hassan, Mohamed Samir, Mahmoud O. Aboudeif, Mohamed S. Thabet, Mona Abdullatif, Dina Khedr
    Journal of Pediatric Endocrinology and Metabolism.2024;[Epub]     CrossRef
  • Improvement of blood glucose control and reduction of hypoglycemia, body weight, and C-reactive protein in type 1 diabetic patients treated with intensive insulin therapy with insulin analogs
    Sasa Radenkovic, Milena Velojic-Golubovic, Dragan Dimic, Danijela Radojkovic, Vojislav Ciric, Milica Pesic
    Vojnosanitetski pregled.2024; 81(8): 480.     CrossRef
  • Explainable Machine-Learning Models to Predict Weekly Risk of Hyperglycemia, Hypoglycemia, and Glycemic Variability in Patients With Type 1 Diabetes Based on Continuous Glucose Monitoring
    Simon Lebech Cichosz, Søren Schou Olesen, Morten Hasselstrøm Jensen
    Journal of Diabetes Science and Technology.2024;[Epub]     CrossRef
  • Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time!
    John Walsh, Ruth Roberts, Timothy S. Bailey, Lutz Heinemann
    Journal of Diabetes Science and Technology.2023; 17(4): 1066.     CrossRef
  • A randomised crossover trial: Exploring the dose–response effect of carbohydrate restriction on glycaemia in people with well‐controlled type 2 diabetes
    Ebaa Al‐Ozairi, Al Awadi Reem, Abeer El Samad, Etab Taghadom, Jumana Al‐Kandari, Muhammad Abdul‐Ghani, Nick Oliver, Brandon Whitcher, Nicola Guess
    Journal of Human Nutrition and Dietetics.2023; 36(1): 51.     CrossRef
  • Monitoring of continuous subcutaneous insulin infusion treatment in Portugal and its implications for diabetes management
    Ana Rita Figueiredo, Tânia Matos, Sónia do Vale
    Hormones.2023; 22(1): 87.     CrossRef
  • A composite measure of sleep health is associated with glycaemic target achievement in young adults with type 1 diabetes
    Stephanie Griggs, Grant Pignatiello, Ronald L. Hickman
    Journal of Sleep Research.2023;[Epub]     CrossRef
  • Comparison of Point-of-Care and Laboratory Glycated Hemoglobin A1c and Its Relationship to Time-in-Range and Glucose Variability: A Real-World Study
    Ayman Al Hayek, Wael M Alzahrani, Samia H Sobki, Abdulghani H Al-Saeed, Mohamed Al Dawish
    Cureus.2023;[Epub]     CrossRef
  • HIF-1α accumulation in response to transient hypoglycemia may worsen diabetic eye disease
    Chuanyu Guo, Monika Deshpande, Yueqi Niu, Isha Kachwala, Miguel Flores-Bellver, Haley Megarity, Taylor Nuse, Savalan Babapoor-Farrokhran, Michael Ramada, Jaron Sanchez, Neelay Inamdar, Thomas V. Johnson, Maria Valeria Canto-Soler, Silvia Montaner, Akrit S
    Cell Reports.2023; 42(1): 111976.     CrossRef
  • Machine Learning–Based Time in Patterns for Blood Glucose Fluctuation Pattern Recognition in Type 1 Diabetes Management: Development and Validation Study
    Nicholas Berin Chan, Weizi Li, Theingi Aung, Eghosa Bazuaye, Rosa M Montero
    JMIR AI.2023; 2: e45450.     CrossRef
  • Continuous Glucose Monitoring in Dogs and Cats
    Francesca Del Baldo, Federico Fracassi
    Veterinary Clinics of North America: Small Animal Practice.2023; 53(3): 591.     CrossRef
  • Hypoglycemia and glycemic variability of people with type 1 diabetes with lower and higher physical activity loads in free-living conditions using continuous subcutaneous insulin infusion with predictive low-glucose suspend system
    Denise Montt-Blanchard, Raimundo Sánchez, Karen Dubois-Camacho, Jaime Leppe, María Teresa Onetto
    BMJ Open Diabetes Research & Care.2023; 11(2): e003082.     CrossRef
  • In vivo photoacoustic monitoring of vasoconstriction induced by acute hyperglycemia
    Joongho Ahn, Jin Woo Baik, Donggyu Kim, Karam Choi, Seunghyun Lee, Sung-Min Park, Jin Young Kim, Sung Hyun Nam, Chulhong Kim
    Photoacoustics.2023; 30: 100485.     CrossRef
  • Oscillating Glucose Induces the Increase in Inflammatory Stress through Ninjurin-1 Up-Regulation and Stimulation of Transport Proteins in Human Endothelial Cells
    Laura Toma, Gabriela M. Sanda, Camelia S. Stancu, Loredan S. Niculescu, Mina Raileanu, Anca V. Sima
    Biomolecules.2023; 13(4): 626.     CrossRef
  • The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies
    Niloofar Deravi, Yasaman Sharifi, Fatemeh Koohi, Seyed Saeed Tamehri Zadeh, Soroush Masrouri, Fereidoun Azizi, Farzad Hadaegh
    BMC Public Health.2023;[Epub]     CrossRef
  • Insight into continuous glucose monitoring: from medical basics to commercialized devices
    Ayman Chmayssem, Małgorzata Nadolska, Emily Tubbs, Kamila Sadowska, Pankaj Vadgma, Isao Shitanda, Seiya Tsujimura, Youssef Lattach, Martin Peacock, Sophie Tingry, Stéphane Marinesco, Pascal Mailley, Sandrine Lablanche, Pierre Yves Benhamou, Abdelkader Zeb
    Microchimica Acta.2023;[Epub]     CrossRef
  • The efficacy and tolerability of intermittent prandial acarbose to reduce glucose spikes in healthy individuals
    A. Isman, A. Nyquist, M. Moel, X. Zhang, S. Zalzala
    Translational Medicine of Aging.2023; 7: 12.     CrossRef
  • Development of an artificial intelligence system to identify hypoglycaemia via ECG in adults with type 1 diabetes: protocol for data collection under controlled and free-living conditions
    Owain Cisuelo, Katy Stokes, Iyabosola B Oronti, Muhammad Salman Haleem, Thomas M Barber, Martin O Weickert, Leandro Pecchia, John Hattersley
    BMJ Open.2023; 13(4): e067899.     CrossRef
  • Self-Management and Glycemic Targets in Adult Haitian Immigrants With Type 2 Diabetes: Research Protocol
    Cherlie Magny-Normilus, Robin Whittemore, Marcella Nunez-Smith, Christopher S. Lee, Jeffrey L. Schnipper, Deborah J. Wexler, Julie A. Sanders, Margaret Grey
    Nursing Research.2023;[Epub]     CrossRef
  • The effect of traditional diet on glucose homoeostasis in carriers and non-carriers of a common TBC1D4 variant in Greenlandic Inuit: a randomised crossover study
    Jack Ivor Lewis, Mads Vendelbo Lind, Grith Møller, Torben Hansen, Hanne Pedersen, Marie Mathilde Bjerg Christensen, Jens Christian Laursen, Sara Nielsen, Charlotte B. Ottendahl, Christina V. Lytken Larsen, Ken D. Stark, Peter Bjerregaard, Marit E. Jørgens
    British Journal of Nutrition.2023; 130(11): 1871.     CrossRef
  • Screening for Impaired Glucose Homeostasis: A Novel Metric of Glycemic Control
    Jaycee M. Kaufman, Lennaert van Veen, Yan Fossat
    Mayo Clinic Proceedings: Digital Health.2023; 1(2): 189.     CrossRef
  • Impact of a Low-Carbohydrate Compared with Low-Fat Breakfast on Blood Glucose Control in Type 2 Diabetes: A Randomized Trial
    Barbara F. Oliveira, Courtney R. Chang, Kate Oetsch, Kaja Falkenhain, Kara Crampton, Matthew Stork, Malvinder Hoonjan, Thomas Elliott, Monique E. Francois, Jonathan P. Little
    The American Journal of Clinical Nutrition.2023; 118(1): 209.     CrossRef
  • Time in Range Estimation in Patients with Type 2 Diabetes is Improved by Incorporating Fasting and Postprandial Glucose Levels
    Rui Sun, Yanli Duan, Yumei Zhang, Lingge Feng, Bo Ding, Rengna Yan, Jianhua Ma, Xiaofei Su
    Diabetes Therapy.2023; 14(8): 1373.     CrossRef
  • Glucose variability: a new risk factor for cardiovascular disease
    Martina Belli, Alfonso Bellia, Domenico Sergi, Lucy Barone, Davide Lauro, Francesco Barillà
    Acta Diabetologica.2023; 60(10): 1291.     CrossRef
  • Effect of Repeated Bolus and Continuous Glucose Infusion on DNA Damage and Oxidative Stress Biomarkers in Healthy Male Volunteers
    Laura Bragagna, Christina Polak, Lisa Schütz, Lina Maqboul, Carmen Klammer, Roland Feldbauer, Agnes Draxler, Martin Clodi, Karl-Heinz Wagner
    International Journal of Molecular Sciences.2023; 24(17): 13608.     CrossRef
  • Association between inpatient glycemic variability and COVID-19 mortality: a prospective study
    Salma Ali El Chab Parolin, Rebecca Benicio Stocco, Julia do Carmo Kneipp Lopes, Marcos Roberto Curcio Pereira, Milena Massae Yamashita, Maria Eduarda Domareski Goulart, Henrique Demeneck, Marcia Olandoski, Larissa Hermann de Souza Nunes, Victor Keniche Mo
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Understanding temporal changes and seasonal variations in glycemic trends using wearable data
    Prajakta Belsare, Abigail Bartolome, Catherine Stanger, Temiloluwa Prioleau
    Science Advances.2023;[Epub]     CrossRef
  • Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
    Ziyu Meng, Chengye Xu, Haoling Liu, Xinyuan Gao, Xinyu Li, Wenjian Lin, Xuefei Ma, Changwei Yang, Ming Hao, Kangqi Zhao, Yuxin Hu, Yi Wang, Hongyu Kuang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes
    Michaela Waibel, John M. Wentworth, Michelle So, Jennifer J. Couper, Fergus J. Cameron, Richard J. MacIsaac, Gabby Atlas, Alexandra Gorelik, Sara Litwak, Laura Sanz-Villanueva, Prerak Trivedi, Simi Ahmed, Francis J. Martin, Madeleine E. Doyle, Jessica E.
    New England Journal of Medicine.2023; 389(23): 2140.     CrossRef
  • Metabolic Stress of Red Blood Cells Induces Hemoglobin Glutathionylation
    P. I. Zaripov, Yu. D. Kuleshova, Yu. M. Poluektov, S. V. Sidorenko, O. K. Kvan, G. V. Maksimov, V. A. Mitkevich, A. A. Makarov, I. Yu. Petrushanko
    Molecular Biology.2023; 57(6): 1176.     CrossRef
  • How to Measure Glycemic Variability? A Literature Review
    Sandra Lazar, Ioana Ionita, Delia Reurean-Pintilei, Bogdan Timar
    Medicina.2023; 60(1): 61.     CrossRef
  • Metabolic Stress of Red Blood Cells Induces Hemoglobin Glutathionylation
    P. I. Zaripov, Iu. D. Kuleshova, Yu. M. Poluektov, S. V. Sidorenko, O. K. Kvan, G. V. Maksimov, V. A. Mitkevich, A. A. Makarov, I. Yu. Petrushanko
    Молекулярная биология.2023; 57(6): 1188.     CrossRef
  • Continuous Glucose Monitoring in Non-Insulin Type 2 Diabetes
    Jothydev Kesavadev, Banshi Saboo, Brij Mohan Makkar, Sanjay Agarwal, Manoj Chawla, Vysakh Chandran, Arun Shankar, Anjana Basanth
    International Journal of Diabetes and Technology.2023; 2(1): 16.     CrossRef
  • A New Analysis Tool for Continuous Glucose Monitor Data
    Evan Olawsky, Yuan Zhang, Lynn E Eberly, Erika S Helgeson, Lisa S Chow
    Journal of Diabetes Science and Technology.2022; 16(6): 1496.     CrossRef
  • Variations in Sleep Characteristics and Glucose Regulation in Young Adults With Type 1 Diabetes
    Stephanie Griggs, Margaret Grey, Kingman P Strohl, Sybil L Crawford, Seunghee Margevicius, Sangeeta R Kashyap, Chiang-Shan R Li, Sanjay Rajagopalan, Ronald L Hickman
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(3): e1085.     CrossRef
  • Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes: A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III)
    Ling Li, Tao Yang, Yaoming Xue, Pengfei Ruan, Juan Du, Yunguang Li, Xia Zhang, Nan Cui, Wenying Yang
    Advances in Therapy.2022; 39(1): 421.     CrossRef
  • Diet and Physical Activity as Determinants of Continuously Measured Glucose Levels in Persons at High Risk of Type 2 Diabetes
    Su Hyun Park, Jiali Yao, Xin Hui Chua, Suresh Rama Chandran, Daphne S. L. Gardner, Chin Meng Khoo, Falk Müller-Riemenschneider, Clare Whitton, Rob M. van Dam
    Nutrients.2022; 14(2): 366.     CrossRef
  • Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice
    Selcuk Dagdelen, Oguzhan Deyneli, Nevin Dinccag, Hasan Ilkova, Zeynep Osar Siva, Ilhan Yetkin, Temel Yilmaz
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Influence of Glucose Fluctuation on Peripheral Nerve Damage in Streptozotocin-Induced Diabetic Rats
    Yu Ji Kim, Na Young Lee, Kyung Ae Lee, Tae Sun Park, Heung Yong Jin
    Diabetes & Metabolism Journal.2022; 46(1): 117.     CrossRef
  • Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
    Ji Cheol Bae, Soo Heon Kwak, Hyun Jin Kim, Sang-Yong Kim, You-Cheol Hwang, Sunghwan Suh, Bok Jin Hyun, Ji Eun Cha, Jong Chul Won, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2022; 46(1): 81.     CrossRef
  • Glycemic Variability and Other Risk Factors for Diabetic Retinopathy
    Amruta S. Kulkarni, Karakkattu V. Kavitha, Nikita S. Sarkar, Vedavati B. Purandare, Savita Bhat, Shalbha Tiwari, Ambika G. Unnikrishnan
    Chronicle of Diabetes Research and Practice.2022; 1(1): 14.     CrossRef
  • Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
    Min Jeong Park, Kyung Mook Choi
    Diabetes & Metabolism Journal.2022; 46(1): 49.     CrossRef
  • Intraoperative Glycemic Variability and Mean Glucose are Predictors for Postoperative Delirium After Cardiac Surgery: A Retrospective Cohort Study
    Hoon Choi, Chul Soo Park, Jaewon Huh, Jungmin Koo, Joonpyo Jeon, Eunsung Kim, Sangmin Jung, Hwan Wook Kim, Ju Yong Lim, Wonjung Hwang
    Clinical Interventions in Aging.2022; Volume 17: 79.     CrossRef
  • The Impact and Clinical Prediction of Hyperglycemia During Parenteral Nutrition for Nondiabetic Patients After Gastrectomy for Gastric Cancer
    Ning Lan, Xiaohua Chen, Ying Lu, Yujie Zhou, Fei Kong, Yining Zhao, Fuzhi Jiao, Lin Zhang, Wenzhen Yuan
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • High glycemic variability: An underestimated determinant of stroke functional outcome following large vessel occlusion
    J. Baudu, E. Gerbaud, B. Catargi, M. Montaudon, M.-C. Beauvieux, S. Sagnier, S. Debruxelles, P. Renou, M. Poli, S. Olindo, M. Couture, G. Marnat, I. Sibon
    Revue Neurologique.2022; 178(7): 732.     CrossRef
  • Glycaemic Variability and Hyperglycaemia as Prognostic Markers of Major Cardiovascular Events in Diabetic Patients Hospitalised in Cardiology Intensive Care Unit for Acute Heart Failure
    Edouard Gerbaud, Ambroise Bouchard de La Poterie, Thomas Baudinet, Michel Montaudon, Marie-Christine Beauvieux, Anne-Iris Lemaître, Laura Cetran, Benjamin Seguy, François Picard, Fritz-Line Vélayoudom, Alexandre Ouattara, Rémi Kabore, Pierre Coste, Pierre
    Journal of Clinical Medicine.2022; 11(6): 1549.     CrossRef
  • The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review
    Evanthia Gouveri, Nikolaos Papanas
    Diabetes Therapy.2022; 13(5): 931.     CrossRef
  • Objective Sleep-Wake Characteristics Are Associated With Diabetes Symptoms in Young Adults With Type 1 Diabetes
    Stephanie Griggs, Margaret Grey, Garrett I. Ash, Chiang-shan R. Li, Sybil L. Crawford, Ronald L. Hickman
    The Science of Diabetes Self-Management and Care.2022; 48(3): 149.     CrossRef
  • The Reproducibility and Usefulness of Estimated Average Glucose for Hyperglycemia Management during Health Checkups: A Retrospective Cross-Sectional Study
    Eun-Hee Nah, Seon Cho, Hyeran Park, Dongwon Noh, Eunjoo Kwon, Han-Ik Cho
    Healthcare.2022; 10(5): 824.     CrossRef
  • Effects of a Novel Blood Glucose Forecasting Feature on Glycemic Management and Logging in Adults With Type 2 Diabetes Using One Drop: Retrospective Cohort Study
    Steven D Imrisek, Matthew Lee, Dan Goldner, Harpreet Nagra, Lindsey M Lavaysse, Jamillah Hoy-Rosas, Jeff Dachis, Lindsay E Sears
    JMIR Diabetes.2022; 7(2): e34624.     CrossRef
  • Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study
    Noppadol Kietsiriroje, Sam M Pearson, Lauren L O’Mahoney, Daniel J West, Robert AS Ariëns, Ramzi A Ajjan, Matthew D Campbell
    Diabetes and Vascular Disease Research.2022;[Epub]     CrossRef
  • Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
    SuA Oh, Sujata Purja, Hocheol Shin, Minji Kim, Eunyoung Kim
    Diabetes and Vascular Disease Research.2022;[Epub]     CrossRef
  • Helpful or harmful? The impact of the ketogenic diet on eating disorder outcomes in type 1 diabetes mellitus
    Suzanne Schneider, Deborah L Biggerstaff, Thomas M Barber
    Expert Review of Endocrinology & Metabolism.2022; 17(4): 319.     CrossRef
  • Feline Comorbidities: Clinical perspective on diabetes mellitus and pancreatitis
    Panagiotis G Xenoulis, Federico Fracassi
    Journal of Feline Medicine and Surgery.2022; 24(7): 651.     CrossRef
  • Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
    Christoph Nowak, Marcus Lind, Zdenek Sumnik, Terezie Pelikanova, Lía Nattero-Chavez, Elena Lundberg, Itxaso Rica, Maria A Martínez-Brocca, MariSol Ruiz de Adana, Jeanette Wahlberg, Ragnar Hanas, Cristina Hernandez, Maria Clemente-León, Ana Gómez-Gila, Mar
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(9): 2644.     CrossRef
  • Serum Glucose Variability Increases the Risk of Complications Following Aseptic Revision Hip and Knee Arthroplasty
    Graham S. Goh, Noam Shohat, Mohammad S. Abdelaal, Ilan Small, Terence Thomas, Kerri-Anne Ciesielka, Javad Parvizi
    Journal of Bone and Joint Surgery.2022; 104(18): 1614.     CrossRef
  • Glycemic Variability in Type 1 Diabetes Mellitus Pregnancies—Novel Parameters in Predicting Large-for-Gestational-Age Neonates: A Prospective Cohort Study
    Gloria Leksic, Maja Baretić, Lara Gudelj, Marija Radic, Iva Milicic, Marina Ivanišević, Dubravka Jurisic-Erzen
    Biomedicines.2022; 10(9): 2175.     CrossRef
  • Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: A retrospective study
    Hongyan Yang, Miao Xia, Zanchao Liu, Yuwei Xing, Weili Zhao, Yang Li, Minzhen Wang, Zengyi Zhao
    Journal of Diabetes and its Complications.2022; 36(11): 108313.     CrossRef
  • Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study
    Kate M. Bermingham, Inbar Linenberg, Wendy L. Hall, Kirstin Kadé, Paul W. Franks, Richard Davies, Jonathan Wolf, George Hadjigeorgiou, Francesco Asnicar, Nicola Segata, JoAnn E. Manson, Louise R. Newson, Linda M. Delahanty, Jose M. Ordovas, Andrew T. Chan
    eBioMedicine.2022; 85: 104303.     CrossRef
  • Continuous glucose monitoring for detection of glycemic variability, hypoglycemia, and hyperglycemia in women with eating disorders
    Nao Uotani, Shun’ichi Noma, Momoko Akamine, Takashi Miyawaki
    BioPsychoSocial Medicine.2022;[Epub]     CrossRef
  • Mining associations between glycemic variability in awake-time and in-sleep among non-diabetic adults
    Zilu Liang
    Frontiers in Medical Technology.2022;[Epub]     CrossRef
  • Dynamic circadian fluctuations of glycemia in patients with type 2 diabetes mellitus
    Manuel Vásquez-Muñoz, Alexis Arce-Álvarez, Cristian Álvarez, Rodrigo Ramírez-Campillo, Fernando A. Crespo, Dayana Arias, Camila Salazar-Ardiles, Mikel Izquierdo, David C. Andrade
    Biological Research.2022;[Epub]     CrossRef
  • Menopause Is Associated With Postprandial Metabolism, Metabolic Health and Lifestyle: The ZOE PREDICT Study
    Kate Bermingham, Inbar Linenberg, Wendy L. Hall, Kirstin Kadé, Paul Franks, Richard Davies, Jonathan Wolf, Francesco Asnicar, Nicola Segata, JoAnn E. Manson, Louise Newson, Linda M. Delahanty, Jose Ordovas, Andrew T. Chan, Tim D. Spector, Ana Valdes, Sara
    SSRN Electronic Journal .2022;[Epub]     CrossRef
  • Continuous Glucose Monitoring-Assisted Insulin Dose Titration in the Indian Outpatient Setting
    Sri Ramya Ganti, Kalyan Chakravarthy Gurazada
    International Journal of Diabetes and Technology.2022; 1(2): 75.     CrossRef
  • Effectiveness of blood glucose control protocol for open heart surgery patients
    Hye Jin Yoo, Eunyoung E. Suh, JaeLan Shim
    Journal of Advanced Nursing.2021; 77(1): 275.     CrossRef
  • Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
    Seung-Hwan Lee, Kyung-Wan Min, Byung-Wan Lee, In-Kyung Jeong, Soon-Jib Yoo, Hyuk-Sang Kwon, Yoon-Hee Choi, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2021; 45(3): 339.     CrossRef
  • Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose
    Selvam Kasthuri, Subramani Poongothai, Ranjit Mohan Anjana, Jayvel Selvakumar, Subramaniam Muthukumar, Sengottuevel Kayalvizhi, Syed Tariq, Evangelin Honey, Prasanna Kumar Gupta, Ulagamathesan Venkatesan, Viswanathan Mohan
    Diabetes Technology & Therapeutics.2021; 23(3): 213.     CrossRef
  • Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus
    Channabasappa Shivaprasad, Yalamanchi Aiswarya, Shah Kejal, Atluri Sridevi, Biswas Anupam, Barure Ramdas, Kolla Gautham, Premchander Aarudhra
    Journal of Diabetes Science and Technology.2021; 15(1): 134.     CrossRef
  • Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic Control
    Emily C Soriano, James M Lenhard, Jeffrey S Gonzalez, Howard Tennen, Sy-Miin Chow, Amy K Otto, Christine Perndorfer, Biing-Jiun Shen, Scott D Siegel, Jean-Philippe Laurenceau
    Annals of Behavioral Medicine.2021; 55(2): 123.     CrossRef
  • Effects of Structured Aerobic Exercise on Selected Clinical Profiles of Patients With Type 2 Diabetes Mellitus
    Nmachukwu Ifeoma Ekechukwu, Stella Udumma Anwara, Ukamaka Gloria Mgbeojedo, Olive U. Chijioke, Okechukwu Steven Onwukwe, Uchechukwu Anthonia Ezugwu, Echezona Nelson Dominic Ekechukwu, Ijeoma L. Okoronkwo
    International Journal of Medicine and Health Development.2021; 26(1): 17.     CrossRef
  • New Innovation: Use of Flash Glucose Monitoring for Evaluating Glycaemic Variability, Patient Satisfaction and Clinical Utility in Pregnant Women with Diabetes
    Saxena Pikee, Kumari Khushbu, Prakash Anupam, Puri Manju, Jain Sachin
    The Journal of Obstetrics and Gynecology of India.2021; 71(2): 136.     CrossRef
  • Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
    Bao Sun, Zhiying Luo, Jiecan Zhou
    Cardiovascular Diabetology.2021;[Epub]     CrossRef
  • The Added and Interpretative Value of CGM-Derived Parameters in Type 1 Diabetes Depends on the Level of Glycemic Control
    Simon Helleputte, Tine De Backer, Patrick Calders, Bart Pauwels, Samyah Shadid, Bruno Lapauw
    Endocrine Practice.2021; 27(1): 44.     CrossRef
  • Short-term glycemic variability and hemorrhagic transformation after successful endovascular thrombectomy
    Tae Jung Kim, Ji Sung Lee, Soo-Hyun Park, Sang-Bae Ko
    Translational Stroke Research.2021; 12(6): 968.     CrossRef
  • The relationship between glycemic variability and blood pressure variability in normoglycemic normotensive individuals
    Havva Sezer, Dilek Yazici, Sidar Copur, Tuncay Dagel, Oguzhan Deyneli, Mehmet Kanbay
    Blood Pressure Monitoring.2021; 26(2): 102.     CrossRef
  • Current concepts and clinical importance of glycemic variability
    Ramya Ravi, V Balasubramaniam, Gowthamarajan Kuppusamy, Sivasankaran Ponnusankar
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(2): 627.     CrossRef
  • Oscillatory pattern of glycemic control in patients with diabetes mellitus
    Manuel Vasquez-Muñoz, Alexis Arce-Alvarez, Magdalena von Igel, Carlos Veliz, Gonzalo Ruiz-Esquide, Rodrigo Ramirez-Campillo, Cristian Alvarez, Robinson Ramirez-Velez, Fernando A. Crespo, Mikel Izquierdo, Rodrigo Del Rio, David C. Andrade
    Scientific Reports.2021;[Epub]     CrossRef
  • Comparing the Efficacies of Telemedicine and Standard Prenatal Care on Blood Glucose Control in Women With Gestational Diabetes Mellitus: Randomized Controlled Trial
    Ying Tian, Suhan Zhang, Feiling Huang, Liangkun Ma
    JMIR mHealth and uHealth.2021; 9(5): e22881.     CrossRef
  • Interpreting blood GLUcose data with R package iglu
    Steven Broll, Jacek Urbanek, David Buchanan, Elizabeth Chun, John Muschelli, Naresh M. Punjabi, Irina Gaynanova, Laura Pyle
    PLOS ONE.2021; 16(4): e0248560.     CrossRef
  • Weight fluctuation and risk of hepatocellular carcinoma: a nationwide population-based 8-million-subject study
    Young Chang, Jeong-Ju Yoo, Eun Ju Cho, Kyungdo Han, Dahye Kim, Bo-Yeon Kim, Goh Eun Chung, Yuri Cho, Dong Wook Shin, Su Jong Yu
    Hepatology International.2021; 15(2): 482.     CrossRef
  • Glucose variability predicts 6-month mortality in patients hospitalized with acute heart failure
    Filipe M. Cunha, Catarina Cidade-Rodrigues, Catarina Elias, Diana Oliveira, Paulo Bettencourt, Patrícia Lourenço
    Internal and Emergency Medicine.2021; 16(8): 2121.     CrossRef
  • Glucose Variability and Risk of Hepatocellular Carcinoma in Patients with Diabetes: A Nationwide Population-Based Study
    Jeong-Ju Yoo, Eun Ju Cho, Kyungdo Han, Soo Seong Heo, Bo-Yeon Kim, Dong Wook Shin, Su Jong Yu
    Cancer Epidemiology, Biomarkers & Prevention.2021; 30(5): 974.     CrossRef
  • Sleep-wake characteristics, daytime sleepiness, and glycemia in young adults with type 1 diabetes
    Stephanie Griggs, Ronald L. Hickman, Kingman P. Strohl, Nancy S. Redeker, Sybil L. Crawford, Margaret Grey
    Journal of Clinical Sleep Medicine.2021; 17(9): 1865.     CrossRef
  • Glycemic Variability in Type 1 Diabetes Mellitus Saudis Using Ambulatory Glucose Profile
    Bader Alzahrani, Saad Alzahrani, Mussa H Almalki, Souha S Elabd, Shawana Abdulhamid Khan, Badurudeen Buhary, Naji Aljuhani, Anwar A Jammah
    Clinical Medicine Insights: Endocrinology and Diabetes.2021;[Epub]     CrossRef
  • Effect of glucose concentration and culture substrate on HUVECs viability in in vitro cultures: A literature review and own results
    Anna Ciechanowska, Ilona Gora, Stanislawa Sabalinska, Piotr Foltynski, Piotr Ladyzynski
    Biocybernetics and Biomedical Engineering.2021; 41(4): 1390.     CrossRef
  • Probabilistic Model of Transition between Categories of Glucose Profiles in Patients with Type 1 Diabetes Using a Compositional Data Analysis Approach
    Lyvia Biagi, Arthur Bertachi, Marga Giménez, Ignacio Conget, Jorge Bondia, Josep Antoni Martín-Fernández, Josep Vehí
    Sensors.2021; 21(11): 3593.     CrossRef
  • Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches
    Brinnae Bent, Peter J. Cho, Maria Henriquez, April Wittmann, Connie Thacker, Mark Feinglos, Matthew J. Crowley, Jessilyn P. Dunn
    npj Digital Medicine.2021;[Epub]     CrossRef
  • Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
    Brinnae Bent, Peter J Cho, April Wittmann, Connie Thacker, Srikanth Muppidi, Michael Snyder, Matthew J Crowley, Mark Feinglos, Jessilyn P Dunn
    BMJ Open Diabetes Research & Care.2021; 9(1): e002027.     CrossRef
  • Circadian characteristics of the rest-activity rhythm, executive function, and glucose fluctuations in young adults with type 1 diabetes
    Stephanie Griggs, Kingman P. Strohl, Margaret Grey, Eric Barbato, Seunghee Margevicius, Ronald L. Hickman
    Chronobiology International.2021; 38(10): 1477.     CrossRef
  • Glucose forecasting using genetic programming and latent glucose variability features
    Sergio Contador, J. Manuel Velasco, Oscar Garnica, J. Ignacio Hidalgo
    Applied Soft Computing.2021; 110: 107609.     CrossRef
  • On the efficacy of behavior change techniques in mHealth for self-management of diabetes: A meta-analysis
    Omar El-Gayar, Martinson Ofori, Nevine Nawar
    Journal of Biomedical Informatics.2021; 119: 103839.     CrossRef
  • Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
    Seung Min Chung, Yun Hee Lee, Chang Oh Kim, Ji Yeon Lee, Sang-Man Jin, Seung-Hyun Yoo, Jun Sung Moon, Kwang Joon Kim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Glucose Patterns in Very Old Adults: A Pilot Study in a Community-Based Population
    Elizabeth Selvin, Dan Wang, Olive Tang, Melissa Minotti, Justin B. Echouffo-Tcheugui, Josef Coresh
    Diabetes Technology & Therapeutics.2021;[Epub]     CrossRef
  • Uma Visão Bioquímica Dos Exames Laboratoriais Prévios Para Iniciantes Na Prática De Corrida De Forma Recreativa E A Importância De Realizá-Los
    João Henrique Pereira De Oliveira
    Revista Científica Multidisciplinar Núcleo do Conhecimento.2021; : 81.     CrossRef
  • Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program
    Paramesh Shamanna, Mala Dharmalingam, Rakesh Sahay, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan Kleinman, Mohamed Thajudeen
    Scientific Reports.2021;[Epub]     CrossRef
  • The role of T‐cell immunity in COVID‐19 severity amongst people living with type II diabetes
    Zhen Wei Marcus Tong, Emma Grant, Stephanie Gras, Melanie Wu, Corey Smith, Helen L. Barrett, Linda A. Gallo, Kirsty R. Short
    The FEBS Journal.2021; 288(17): 5042.     CrossRef
  • The Role of Glycemic Variability in Cardiovascular Disorders
    Valentina Alfieri, Veronika A. Myasoedova, Maria Cristina Vinci, Maurizio Rondinelli, Paola Songia, Ilaria Massaiu, Nicola Cosentino, Donato Moschetta, Vincenza Valerio, Michele Ciccarelli, Giancarlo Marenzi, Stefano Genovese, Paolo Poggio
    International Journal of Molecular Sciences.2021; 22(16): 8393.     CrossRef
  • Impact of tacrolimus variability on pediatric heart transplant outcomes
    Megan Sirota, Caroline Heyrend, Zhining Ou, Susan Masotti, Eric Griffiths, Kimberly Molina
    Pediatric Transplantation.2021;[Epub]     CrossRef
  • Prevalence of glycemic variability and factors associated with the glycemic arrays among end-stage kidney disease patients on chronic hemodialysis
    Abdul Hanif Khan Yusof Khan, Nor Fadhlina Zakaria, Muhammad Adil Zainal Abidin, Nor Azmi Kamaruddin
    Medicine.2021; 100(30): e26729.     CrossRef
  • Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review
    Delphine Tinguely, Justine Gross, Christophe Kosinski
    Current Diabetes Reports.2021;[Epub]     CrossRef
  • Glucose variability and low bone turnover in people with type 2 diabetes
    Jakob Starup-Linde, Simon Lykkeboe, Aase Handberg, Peter Vestergaard, Pernille Høyem, Jesper Fleischer, Troels Krarup Hansen, Per Løgstrup Poulsen, Esben Laugesen
    Bone.2021; 153: 116159.     CrossRef
  • Use of continuous glucose monitoring in obesity research: A scoping review
    Elizabeth Hegedus, Sarah-Jeanne Salvy, Choo Phei Wee, Monica Naguib, Jennifer K. Raymond, D. Steven Fox, Alaina P. Vidmar
    Obesity Research & Clinical Practice.2021; 15(5): 431.     CrossRef
  • The Association Between Mean Glycated Haemoglobin or Glycaemic Variability and the Development of Retinopathy in People with Diabetes: A Retrospective Observational Cohort Study
    Ketan Dhatariya, Alexander Humberstone, Abul Hasnat, Rebecca Wright, Morgan Lujan, Ian Nunney
    Diabetes Therapy.2021; 12(10): 2755.     CrossRef
  • Improved Glycemic Control and Variability: Application of Healthy Ingredients in Asian Staples
    Stefan Gerardus Camps, Bhupinder Kaur, Joseph Lim, Yi Ting Loo, Eunice Pang, Terence Ng, Christiani Jeyakumar Henry
    Nutrients.2021; 13(9): 3102.     CrossRef
  • Glycemic Variability Impacted by SGLT2 Inhibitors and GLP 1 Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Heeyoung Lee, Se-eun Park, Eun-Young Kim
    Journal of Clinical Medicine.2021; 10(18): 4078.     CrossRef
  • Glycemic variability of acute stroke patients and clinical outcomes: a continuous glucose monitoring study
    Lina Palaiodimou, Vasileios-Arsenios Lioutas, Vaia Lambadiari, Aikaterini Theodorou, Marios Themistocleous, Laura Aponte, Georgia Papagiannopoulou, Aikaterini Foska, Eleni Bakola, Rodrigo Quispe, Laura Mendez, Magdy Selim, Vera Novak, Elias Tzavellas, Pan
    Therapeutic Advances in Neurological Disorders.2021;[Epub]     CrossRef
  • Glycemic variability: Importance, relationship with physical activity, and the influence of exercise
    Joshua R. Sparks, Erin E. Kishman, Mark A. Sarzynski, J. Mark Davis, Peter W. Grandjean, J. Larry Durstine, Xuewen Wang
    Sports Medicine and Health Science.2021; 3(4): 183.     CrossRef
  • The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Xingyun Zhu, Lina Zhao, Jing Chen, Chu Lin, Fang Lv, Suiyuan Hu, Xiaoling Cai, Li Zhang, Linong Ji
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Cgmquantify: Python and R Software Packages for Comprehensive Analysis of Interstitial Glucose and Glycemic Variability from Continuous Glucose Monitor Data
    Brinnae Bent, Maria Henriquez, Jessilyn Dunn
    IEEE Open Journal of Engineering in Medicine and Biology.2021; 2: 263.     CrossRef
  • In-Hospital Mortality and Glycemic Control in Patients with Hospital Hyperglycemia
    María Paula Russo, Santiago Nicolas Marquez Fosser, Cristina María Elizondo, Diego Hernán Giunta, Nora Angélica Fuentes, María Florencia Grande-Ratti
    Review of Diabetic Studies.2021; 17(2): 50.     CrossRef
  • Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
    Xiaochun Zhang, Xue Yang, Bao Sun, Chunsheng Zhu
    Communications Biology.2021;[Epub]     CrossRef
  • Association Between Intra-Hospital Uncontrolled Glycemia and Health Outcomes in Patients with Diabetes: A Systematic Review of Observational Studies
    Renata Cunha Carvalho, Fernanda Ayache Nishi, Tatiane Bomfim Ribeiro, Gustavo Galvão França, Patricia Melo Aguiar
    Current Diabetes Reviews.2021; 17(3): 304.     CrossRef
  • Glycaemic Variability Heavily Affects Outcomes of Diabetic Patients Hospitalized for Acute Heart Failure
    Edouard Gerbaud, Ambroise Bouchard de la Poterie, Thomas Baudinet, Michel Montaudon, Marie-Christine Beauvieux, Anne-Iris Lemaître, Laura Cetran, Benjamin Seguy, Francois Picard, Fritz-Line Vélayoudom, Alexandre Ouattara, Rémi Kabore, Pierre Coste, Pierre
    SSRN Electronic Journal .2021;[Epub]     CrossRef
  • Understanding Glycemic Variability
    Vedavati Bharat Purandare, Charan Bale, Arjun Kakrani, Ambika Gopalakrishnan Unnikrishnan
    Journal of Diabetology.2021; 12(3): 275.     CrossRef
  • Food order and glucose excursion in Indian adults with normal and overweight/obese Body Mass Index: A randomised crossover pilot trial
    Ching Li Lee, Sangeetha Shyam, Zi Yi Lee, Jie Lene Tan
    Nutrition and Health.2021; 27(2): 161.     CrossRef
  • GLU: a software package for analysing continuously measured glucose levels in epidemiology
    Louise A C Millard, Nashita Patel, Kate Tilling, Melanie Lewcock, Peter A Flach, Debbie A Lawlor
    International Journal of Epidemiology.2020; 49(3): 744.     CrossRef
  • Glycemic variability and subsequent malignancies among the population without diabetes
    Daiki Kobayashi, Hiroshi Noto, Osamu Takahashi, Takuro Shimbo
    Diabetes Research and Clinical Practice.2020; 159: 107987.     CrossRef
  • The relationship between glycaemic variability and cardiovascular autonomic dysfunction in patients with type 1 diabetes: A systematic review
    Simon Helleputte, Tine De Backer, Bruno Lapauw, Samyah Shadid, Bert Celie, Birgit Van Eetvelde, Karsten Vanden Wyngaert, Patrick Calders
    Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
  • Actualización sobre hiperglucemia posprandial: fisiopatología, prevalencia, consecuencias e implicaciones para el tratamiento de la diabetes
    P.J. Pinés Corrales, V. Bellido Castañeda, F.J. Ampudia-Blasco
    Revista Clínica Española.2020; 220(1): 57.     CrossRef
  • Sleep, self‐management, neurocognitive function, and glycemia in emerging adults with Type 1 diabetes mellitus: A research protocol
    Stephanie Griggs, Nancy S. Redeker, Sybil L. Crawford, Margaret Grey
    Research in Nursing & Health.2020; 43(4): 317.     CrossRef
  • GLP 1 receptor agonists, glycemic variability, oxidative stress and acute coronary syndrome
    Maria Isabel del Olmo García, Juan Francisco Merino-Torres
    Medical Hypotheses.2020; 136: 109504.     CrossRef
  • Risk factors for hospitalization in youth with type 1 diabetes: Development and validation of a multivariable prediction model
    Juan D Mejia‐Otero, Soumya Adhikari, Perrin C White
    Pediatric Diabetes.2020; 21(7): 1268.     CrossRef
  • Acute and Chronic Effects of Exercise on Continuous Glucose Monitoring Outcomes in Type 2 Diabetes: A Meta-Analysis
    Matthew Munan, Camila L. P. Oliveira, Alexis Marcotte-Chénard, Jordan L. Rees, Carla M. Prado, Eléonor Riesco, Normand G. Boulé
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Age‐specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10‐ year cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Florence Ting Yan Ng, Shu Ming Cheryl Chia, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Diabetes, Obesity and Metabolism.2020; 22(8): 1316.     CrossRef
  • Comparison of Glycemic Variability Indices: Blood Glucose, Risk Index, and Coefficient of Variation in Predicting Adverse Outcomes for Patients Undergoing Cardiac Surgery
    Valluvan Rangasamy, Xinling Xu, Ammu Thampi Susheela, Balachundhar Subramaniam
    Journal of Cardiothoracic and Vascular Anesthesia.2020; 34(7): 1794.     CrossRef
  • Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
    Boris Kovatchev, Zhaoling Meng, Anna M. G. Cali, Riccardo Perfetti, Marc D. Breton
    Diabetes Therapy.2020; 11(6): 1293.     CrossRef
  • Non-Dietary Factors Associated with Glycemic Status among Adults Diagnosed with Type 2 Diabetes Mellitus in Malawi
    Getrude Mphwanthe, Dave Weatherspoon, Alexander Kalimbira, Lorraine Weatherspoon
    Social Work in Public Health.2020; 35(6): 380.     CrossRef
  • Glycaemic profile in the second and third trimesters of normal pregnancy compared to non-pregnant adult females
    Aruna Nigam, Neha Varun, Sumedha Sharma, YP Munjal, Anupam Prakash
    Obstetric Medicine.2020; 13(1): 30.     CrossRef
  • The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial
    Fei Gao, Xiaojing Ma, Jiahui Peng, Jingyi Lu, Wei Lu, Wei Zhu, Yuqian Bao, Robert A. Vigersky, Weiping Jia, Jian Zhou
    Diabetes Technology & Therapeutics.2020; 22(4): 256.     CrossRef
  • Circulating Wnt1-inducible signaling pathway protein-1 (WISP-1/CCN4) is a novel biomarker of adiposity in subjects with type 2 diabetes
    Vadim V. Klimontov, Dinara M. Bulumbaeva, Olga N. Fazullina, Alexander P. Lykov, Natalia P. Bgatova, Nikolay B. Orlov, Vladimir I. Konenkov, Andreas F.H. Pfeiffer, Olga Pivovarova-Ramich, Natalia Rudovich
    Journal of Cell Communication and Signaling.2020; 14(1): 101.     CrossRef
  • Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
    Anna L. Krämer, Angelina Riederer, Federico Fracassi, Felicitas S. Boretti, Nadja S. Sieber‐Ruckstuhl, Thomas A. Lutz, Barbara Contiero, Eric Zini, Claudia E. Reusch
    Journal of Veterinary Internal Medicine.2020; 34(6): 2287.     CrossRef
  • Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study
    Maria Isabel del Olmo-García, David Hervás Marín, Jana Caudet Esteban, Antonio Ballesteros Martin-Portugués, Alba Cerveró Rubio, Miguel Angel Arnau Vives, Ana Catalá Gregori, Maite Penalba Martínez, Juan Francisco Merino-Torres
    Journal of International Medical Research.2020;[Epub]     CrossRef
  • Capturing glucose variability in patients with diabetes
    David Laight
    Prescriber.2020; 31(9): 20.     CrossRef
  • Diabetes of the Exocrine Pancreas Related to Hereditary Pancreatitis, an Update
    Gabriel Xavier Ramalho, Marcio Garrison Dytz
    Current Diabetes Reports.2020;[Epub]     CrossRef
  • Robust estimation of the effect of an exposure on the change in a continuous outcome
    Yilin Ning, Nathalie C. Støer, Peh Joo Ho, Shih Ling Kao, Kee Yuan Ngiam, Eric Yin Hao Khoo, Soo Chin Lee, E-Shyong Tai, Mikael Hartman, Marie Reilly, Chuen Seng Tan
    BMC Medical Research Methodology.2020;[Epub]     CrossRef
  • Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
    Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
    Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
  • Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study
    Guoli Du, Wanrun Xie, Yinxia Su, Yao Ma, Xiaoming Gao, Sheng Jiang, Huazheng Liang
    PeerJ.2020; 8: e9905.     CrossRef
  • Association between sleep disturbances, fear of hypoglycemia and psychological well-being in adults with type 1 diabetes mellitus, data from cross-sectional VARDIA study
    Valentine Suteau, Pierre-Jean Saulnier, Matthieu Wargny, Linda Gonder-Frederick, Elise Gand, Lucy Chaillous, Ingrid Allix, Séverine Dubois, Fabrice Bonnet, Anne-Marie Leguerrier, Gerard Fradet, Ingrid Delcourt Crespin, Véronique Kerlan, Didier Gouet, Caro
    Diabetes Research and Clinical Practice.2020; 160: 107988.     CrossRef
  • Update on postprandial hyperglycemia: The pathophysiology, prevalence, consequences and implications of treating diabetes
    P.J. Pinés Corrales, V. Bellido Castañeda, F.J. Ampudia-Blasco
    Revista Clínica Española (English Edition).2020; 220(1): 57.     CrossRef
  • How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
    R. Livingstone, J. G. Boyle, J. R. Petrie
    Diabetic Medicine.2020; 37(4): 513.     CrossRef
  • In-Silico Evaluation of Glucose Regulation Using Policy Gradient Reinforcement Learning for Patients with Type 1 Diabetes Mellitus
    Jonas Nordhaug Myhre, Miguel Tejedor, Ilkka Kalervo Launonen, Anas El Fathi, Fred Godtliebsen
    Applied Sciences.2020; 10(18): 6350.     CrossRef
  • Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications
    Eleftheria Papachristoforou, Vaia Lambadiari, Eirini Maratou, Konstantinos Makrilakis, Celestino Sardu
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices
    Enrico Longato, Giada Acciaroli, Andrea Facchinetti, Alberto Maran, Giovanni Sparacino
    Journal of Diabetes Science and Technology.2020; 14(2): 297.     CrossRef
  • Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end‐stage renal disease: Results from a randomized, phase 3 study
    Kohei Kaku, Kazuyuki Ishida, Kohei Shimizu, Meguru Achira, Yuusuke Umeda
    Journal of Diabetes Investigation.2020; 11(2): 373.     CrossRef
  • Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
    John Peabody, David Paculdo, M. Czarina Acelajado, Trever Burgon, Jeffrey R. Dahlen
    Journal of Clinical & Translational Endocrinology.2020; 20: 100224.     CrossRef
  • Effects of Exercise on Blood Glucose and Glycemic Variability in Type 2 Diabetic Patients with Dawn Phenomenon
    Xin Zheng, Yanyan Qi, Lina Bi, Wenli Shi, Yan Zhang, Dan Zhao, Su Hu, Meixin Li, Qin Li
    BioMed Research International.2020; 2020: 1.     CrossRef
  • Effects of Cardiovascular Risk Factor Variability on Health Outcomes
    Seung-Hwan Lee, Mee Kyoung Kim, Eun-Jung Rhee
    Endocrinology and Metabolism.2020; 35(2): 217.     CrossRef
  • Increased Preoperative Glucose Variability Is Associated with Adverse Perioperative Outcomes Following Orthopedic Surgery in Patients with Type 2 Diabetes Mellitus
    Si-jie Yuan, Jie Shen
    Current Medical Science.2020; 40(3): 523.     CrossRef
  • Clinically Accurate Prediction of Glucose Levels in Patients with Type 1 Diabetes
    Yotam Amar, Smadar Shilo, Tal Oron, Eran Amar, Moshe Phillip, Eran Segal
    Diabetes Technology & Therapeutics.2020; 22(8): 562.     CrossRef
  • Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis
    Wen-Cheng Chao, Chien-Hua Tseng, Chieh-Liang Wu, Sou-Jen Shih, Chi-Yuan Yi, Ming-Cheng Chan
    Annals of Intensive Care.2020;[Epub]     CrossRef
  • Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes following the First Episode of Cerebral Infarction
    Qingqing Lou, Xiaodan Yuan, Shujie Hao, Joshua D. Miller, Juan Yan, Panpan Zuo, Jianing Li, Lihong Yang, Hong Li
    Journal of Diabetes Research.2020; 2020: 1.     CrossRef
  • Rationale and design of the LIBERATES trial: Protocol for a randomised controlled trial of flash glucose monitoring for optimisation of glycaemia in individuals with type 2 diabetes and recent myocardial infarction
    Colin C Everett, Catherine Reynolds, Catherine Fernandez, Deborah D Stocken, Linda D Sharples, Thozhukat Sathyapalan, Simon Heller, Robert F Storey, Ramzi A Ajjan
    Diabetes and Vascular Disease Research.2020;[Epub]     CrossRef
  • Comparison between a flash glucose monitoring system and a portable blood glucose meter for monitoring dogs with diabetes mellitus
    Francesca Del Baldo, Claudia Canton, Silvia Testa, Harry Swales, Ignazio Drudi, Stefania Golinelli, Federico Fracassi
    Journal of Veterinary Internal Medicine.2020; 34(6): 2296.     CrossRef
  • Effect of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Weight on Emergency Hospitalization and 30‐Day Mortality in the General Population
    Seung‐Hwan Lee, Kyungdo Han, Hyuk‐Sang Kwon, Kun‐Ho Yoon, Mee Kyoung Kim
    Journal of the American Heart Association.2020;[Epub]     CrossRef
  • Accumulating Physical Activity in Short or Brief Bouts for Glycemic Control in Adults With Prediabetes and Diabetes
    Courtney R. Chang, Brooke M. Russell, Paddy C. Dempsey, Hannah E. Christie, Matthew D. Campbell, Monique E. Francois
    Canadian Journal of Diabetes.2020; 44(8): 759.     CrossRef
  • Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
    Jee Hee Yoo, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2020; 44(6): 828.     CrossRef
  • Flash glucose monitoring in diabetic dogs: a feasible method for evaluating glycemic control
    Florian K. Zeugswetter, Andrea Sellner
    Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere.2020; 48(05): 330.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • Efficacy of Real-Time Continuous Glucose Monitoring to Improve Effects of a Prescriptive Lifestyle Intervention in Type 2 Diabetes: A Pilot Study
    Penelope J. Taylor, Campbell H. Thompson, Natalie D. Luscombe-Marsh, Thomas P. Wycherley, Gary Wittert, Grant D. Brinkworth
    Diabetes Therapy.2019; 10(2): 509.     CrossRef
  • The mechanisms of glycemic variability accelerate diabetic central neuropathy and diabetic peripheral neuropathy in diabetic rats
    Junpeng Yang, Zhigang Zhao, Huijuan Yuan, Xiangxiang Ma, Yakun Li, Huimeng Wang, Xiaojun Ma, Guijun Qin
    Biochemical and Biophysical Research Communications.2019; 510(1): 35.     CrossRef
  • Assessment of glucose variability in subjects with prediabetes
    Nevena Chakarova, Rumyana Dimova, Greta Grozeva, Tsvetalina Tankova
    Diabetes Research and Clinical Practice.2019; 151: 56.     CrossRef
  • Phase 1 Study of the Pharmacology of BTI320 Before High‐Glycemic Meals
    David R. Luke, Karen Ka Yan Lee, Carl W. Rausch, Camille Cheng
    Clinical Pharmacology in Drug Development.2019; 8(3): 395.     CrossRef
  • Design and Prestudy Assessment of a Dashboard for Presenting Self-Collected Health Data of Patients With Diabetes to Clinicians: Iterative Approach and Qualitative Case Study
    Alain Giordanengo, Eirik Årsand, Ashenafi Zebene Woldaregay, Meghan Bradway, Astrid Grottland, Gunnar Hartvigsen, Conceição Granja, Torbjørn Torsvik, Anne Helen Hansen
    JMIR Diabetes.2019; 4(3): e14002.     CrossRef
  • Early dysglycemia and mortality in traumatic brain injury and subarachnoid hemorrhage
    Simone Pappacena, Michael Bailey, Luca Cabrini, Giovanni Landoni, Andrew Udy, David V. Pilcher, Paul Young, Rinaldo Bellomo
    Minerva Anestesiologica.2019;[Epub]     CrossRef
  • The state of variability: A vision for descriptors of glycaemia
    Tony Zhou, Jennifer L. Knopp, J. Geoffrey Chase
    Annual Reviews in Control.2019; 48: 472.     CrossRef
  • Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study
    Julia A. Critchley, Iain M. Carey, Tess Harris, Stephen DeWilde, Derek G. Cook
    Diabetes Care.2019; 42(12): 2237.     CrossRef
  • Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring
    Jeremy Pettus, Jasvinder Gill, Sachin Paranjape, John Stewart, Shilpy Malla, Steven Edelman, Richard M. Bergenstal, Bruce Bode
    Diabetes, Obesity and Metabolism.2019; 21(8): 1906.     CrossRef
  • Improved outcome of patients with diabetes mellitus with good glycemic control in the cardiac intensive care unit: a retrospective study
    Kassem Sharif, Suheil Ghadir, Daniela Jakubowicz, Howard Amital, Nicola Luigi Bragazzi, Abdulla Watad, Julio Wainstein, Yosefa Bar-Dayan
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • Short‐term exercise training reduces glycaemic variability and lowers circulating endothelial microparticles in overweight and obese women at elevated risk of type 2 diabetes
    Hossein Rafiei, Emily Robinson, Julianne Barry, Mary Elizabeth Jung, Jonathan Peter Little
    European Journal of Sport Science.2019; 19(8): 1140.     CrossRef
  • Rapid gastric emptying in diabetes mellitus: Pathophysiology and clinical importance
    Raj K. Goyal, Vivian Cristofaro, Maryrose P. Sullivan
    Journal of Diabetes and its Complications.2019; 33(11): 107414.     CrossRef
  • Fine-Scale Online Evaluation of Glycemic Control Performance Based on Temporal Feature Analysis
    Hong Zhao, Chunhui Zhao
    Industrial & Engineering Chemistry Research.2019; 58(11): 4374.     CrossRef
  • Breakfast replacement with a liquid formula improves glycaemic variability in patients with type 2 diabetes: a randomised clinical trial
    Jiahui Peng, Jingyi Lu, Xiaojing Ma, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou
    British Journal of Nutrition.2019; 121(5): 560.     CrossRef
  • Dapagliflozin: A Review in Type 1 Diabetes
    Julia Paik, Hannah A. Blair
    Drugs.2019; 79(17): 1877.     CrossRef
  • Data-Driven Blood Glucose Pattern Classification and Anomalies Detection: Machine-Learning Applications in Type 1 Diabetes
    Ashenafi Zebene Woldaregay, Eirik Årsand, Taxiarchis Botsis, David Albers, Lena Mamykina, Gunnar Hartvigsen
    Journal of Medical Internet Research.2019; 21(5): e11030.     CrossRef
  • Quantitative Assessment of Autonomic Regulation of the Cardiac System
    Jian Kang Wu, Zhipei Huang, Zhiqiang Zhang, Wendong Xiao, Hong Jiang
    Journal of Healthcare Engineering.2019; 2019: 1.     CrossRef
  • Different Types of Physical Activity and Metabolic Control in People With Type 1 Diabetes Mellitus
    Iztok Štotl, Tim Kambič, Vedran Hadžić, Anže Zdolšek
    Frontiers in Physiology.2019;[Epub]     CrossRef
  • A Randomized Pilot Study of the Effect of Trelagliptin and Alogliptin on Glycemic Variability in Patients with Type 2 Diabetes
    Rimei Nishimura, Takeshi Osonoi, Yasuhiro Koike, Kouji Miyata, Yukio Shimasaki
    Advances in Therapy.2019; 36(11): 3096.     CrossRef
  • No association between fear of hypoglycemia and blood glucose variability in type 1 diabetes: The cross-sectional VARDIA study
    Pierre Jean Saulnier, Claire Briet, Elise Gand, Lucy Chaillous, Severine Dubois, Fabrice Bonnet, Anne Marie Leguerrier, Gérard Fradet, Ingrid Delcourt Crespin, Veronique Kerlan, Didier Gouet, Caroline Perlemoine, Pierre Henri Ducluzeau, Matthieu Pichelin,
    Journal of Diabetes and its Complications.2019; 33(8): 554.     CrossRef
  • Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients
    H.B. Østergaard, T. Mandrup-Poulsen, G.F.N. Berkelmans, Y. van der Graaf, F.L.J. Visseren, J. Westerink
    Diabetes & Metabolism.2019; 45(3): 254.     CrossRef
  • Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome
    Edouard Gerbaud, Romain Darier, Michel Montaudon, Marie-Christine Beauvieux, Christine Coffin-Boutreux, Pierre Coste, Hervé Douard, Alexandre Ouattara, Bogdan Catargi
    Diabetes Care.2019; 42(4): 674.     CrossRef
  • General Assembly, Prevention, Host Risk Mitigation - General Factors: Proceedings of International Consensus on Orthopedic Infections
    William Jiranek, James W.M. Kigera, Brian A. Klatt, Fatih Küçükdurmaz, Jay Lieberman, Claus Moser, Kevin Mulhall, Hasan Nahouli, Edward Schwarz, Noam Shohat, Majd Tarabichi
    The Journal of Arthroplasty.2019; 34(2): S43.     CrossRef
  • Fenofibrate increases very-long-chain sphingolipids and improves blood glucose homeostasis in NOD mice
    Laurits J. Holm, Martin Haupt-Jorgensen, Jano D. Giacobini, Jane P. Hasselby, Mesut Bilgin, Karsten Buschard
    Diabetologia.2019; 62(12): 2262.     CrossRef
  • Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability
    V V Klimontov, D M Bulumbaeva, O N Fazullina, N B Orlov, V I Konenkov
    Terapevticheskii arkhiv.2019; 91(10): 28.     CrossRef
  • Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trial
    Shu Meguro, Shingo Matsui, Hiroshi Itoh
    Current Medical Research and Opinion.2019; 35(12): 2071.     CrossRef
  • Glucose Variables in Type 1 Diabetes Studies With Dapagliflozin: Pooled Analysis of Continuous Glucose Monitoring Data From DEPICT-1 and -2
    Chantal Mathieu, Paresh Dandona, Moshe Phillip, Tal Oron, Marcus Lind, Lars Hansen, Fredrik Thorén, John Xu, Anna Maria Langkilde
    Diabetes Care.2019; 42(6): 1081.     CrossRef
  • Time in Range: Ein neuer Parameter – komplementär zum HbA 1c
    Thomas Danne, Olga Kordonouri, Torben Biester, Thorsten Siegmund, Jens Kröger, Peter Bramlage, Thomas Haak
    Deutsches Ärzteblatt Online.2019;[Epub]     CrossRef
  • Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study
    Kris van Keulen, Wilma Knol, Svetlana V. Belitser, Irene J. Zaal, Paul D. van der Linden, Eibert R. Heerdink, Toine C. G. Egberts, Arjen J. C. Slooter, Noël C. Barengo
    PLOS ONE.2018; 13(11): e0205637.     CrossRef
  • Association of various glycemic variability indices and vascular outcomes in type-2 diabetes patients
    Lei Tong, Chen Chi, Zhiguo Zhang
    Medicine.2018; 97(21): e10860.     CrossRef
  • Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes
    Guillermo E. Umpierrez, Boris P. Kovatchev
    The American Journal of the Medical Sciences.2018; 356(6): 518.     CrossRef
  • Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data
    Thomas A. Peyser, Andrew K. Balo, Bruce A. Buckingham, Irl B. Hirsch, Arturo Garcia
    Diabetes Technology & Therapeutics.2018; 20(1): 6.     CrossRef
  • Impact of Insulin Degludec in Hospitalized Patients With and Without Type 2 Diabetes Requiring Parenteral/Enteral Nutrition: An Observational Study
    Giuseppe Fatati, Agnese Di Donato, Ilenia Grandone, Pina Menicocci, Eva Mirri, Giuseppe Prosperini, Marco Scardapane, Maria Chiara Rossi, Mariangela Palazzi
    Advances in Therapy.2018; 35(6): 809.     CrossRef
  • Long-lasting Glucagon-like Peptide 1 Analogue Exendin-4 Ameliorates the Secretory and Synthetic Function of Islets Isolated From Severely Scalded Rats
    Dongxu Zhao, Li Ma, Chuanan Shen, Dawei Li, Wenfeng Cheng, Yuru Shang, Zhaoxing Liu, Xin Wang, Kai Yin
    Journal of Burn Care & Research.2018; 39(4): 545.     CrossRef
  • Social support effects on diabetes management by South African emerging adults: A replication and extension study
    Elné Visagie, Esmé van Rensburg, Elmarí Deacon
    Journal of Psychology in Africa.2018; 28(6): 504.     CrossRef
  • All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty
    Noam Shohat, Karan Goswami, Majd Tarabichi, Emily Sterbis, Timothy L. Tan, Javad Parvizi
    The Journal of Arthroplasty.2018; 33(7): 2057.     CrossRef
  • Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes
    Martin K. Rutter
    Diabetologia.2018; 61(1): 43.     CrossRef
  • Duration of storage influences the hemoglobin rising effect of red blood cells in patients undergoing major abdominal surgery
    Oliver Hunsicker, Katarina Hessler, Alexander Krannich, Willehad Boemke, Ioana Braicu, Jalid Sehouli, Oliver Meyer, Axel Pruß, Claudia Spies, Aarne Feldheiser
    Transfusion.2018; 58(8): 1870.     CrossRef
  • Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus
    Ana M. Gómez, Oscar M. Muñoz, Alejandro Marin, Maria Camila Fonseca, Martin Rondon, María Alejandra Robledo Gómez, Andrei Sanko, Dilcia Lujan, Maira García-Jaramillo, Fabian Mauricio León Vargas
    Journal of Diabetes Science and Technology.2018; 12(5): 1007.     CrossRef
  • Glucose concentrations after insulin‐induced hypoglycemia and glycemic variability in healthy and diabetic cats
    Eric Zini, Elena Salesov, Perrine Dupont, Laura Moretto, Barbara Contiero, Thomas A. Lutz, Claudia E. Reusch
    Journal of Veterinary Internal Medicine.2018; 32(3): 978.     CrossRef
  • Assessment of Glycemic Variability May Be the Next Step in Optimizing Patients for Total Joint Arthroplasty
    Charles N. Cornell
    Journal of Bone and Joint Surgery.2018; 100(13): e92.     CrossRef
  • Glucose Variability and the Use of Continuous Glucose Monitors in People With Type 1 and Type 2 Diabetes
    Betty Lu, Jennifer D. Goldman
    AADE in Practice.2018; 6(6): 22.     CrossRef
  • Emerging Technologies for Diabetes Care
    Timothy S. Bailey, John Walsh, Jenine Y. Stone
    Diabetes Technology & Therapeutics.2018; 20(S2): S2-78.     CrossRef
  • Exercise Timing in Type 2 Diabetes Mellitus: A Systematic Review
    SHAUN Y. M. TEO, JILL A. KANALEY, KYM J. GUELFI, SUMMER B. COOK, JEFFREY J. HEBERT, MITCHELL R. L. FORREST, TIMOTHY J. FAIRCHILD
    Medicine & Science in Sports & Exercise.2018; 50(12): 2387.     CrossRef
  • FATORES DE RISCO ASSOCIADOS À HIPOGLICEMIA E ANÁLISE DE EVENTOS ADVERSOS EM UMA TERAPIA INTENSIVA
    Keroulay Estebanez Roque, Andrea Rodrigues Gomes da Silva, Mario Henrique Bravo de Almeida Santos, Enirtes Caetano Prates Melo
    Texto & Contexto - Enfermagem.2018;[Epub]     CrossRef
  • Decreased Retinal Thickness in Type 1 Diabetic Children with Signs of Nonproliferative Diabetic Retinopathy
    P. Ruiz-Ocaña, P. Espinoza Requena, A. Alonso-Ojembarrena, P. Alemany Márquez, S. Jiménez Carmona, A. M. Lechuga-Sancho
    International Journal of Endocrinology.2018; 2018: 1.     CrossRef
  • The impact of dapagliflozin on glucose excursions related to early proatherogenic derangement in the aortic wall
    Agnieszka Stelmaszyk, Anna Wesołowska, Karolina Pomieczyńska, Saule Iskakova, Magdalena Frydrychowicz, Grzegorz Dworacki, Marzena Dworacka
    Saudi Pharmaceutical Journal.2018; 26(8): 1192.     CrossRef
  • The Relationship Between Social Support and Type 2 Diabetes Risk
    Kristin G. Maki
    Communication Research Reports.2018; 35(1): 12.     CrossRef
  • Early glycemia and mortality in critically ill septic patients: Interaction with insulin-treated diabetes
    Fraser Magee, Michael Bailey, David V. Pilcher, Johan Mårtensson, Rinaldo Bellomo
    Journal of Critical Care.2018; 45: 170.     CrossRef
  • Glycemic behavior in patients with type 2 diabetes during a short period of a combined training program
    Daniela Bassi, Almir Vieira Dibai-Filho, Leonardo Hesley Durans, Renata Gonçalves Mendes, Flávia Cristina Rossi Caruso, Vivian Maria Arakelian, Audrey Borghi-Silva
    Motriz: Revista de Educação Física.2018;[Epub]     CrossRef
  • Glycemic variability in the development of cardiovascular complications in diabetes
    Annunziata Nusca, Dario Tuccinardi, Marzia Albano, Camilla Cavallaro, Elisabetta Ricottini, Silvia Manfrini, Paolo Pozzilli, Germano Di Sciascio
    Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
  • Continuous glucose monitoring: data management and evaluation by patients and health care professionals – current situation and developments
    Guido Freckmann, Jochen Mende
    LaboratoriumsMedizin.2018; 42(6): 225.     CrossRef
  • Glucotypes reveal new patterns of glucose dysregulation
    Heather Hall, Dalia Perelman, Alessandra Breschi, Patricia Limcaoco, Ryan Kellogg, Tracey McLaughlin, Michael Snyder, Jason Locasale
    PLOS Biology.2018; 16(7): e2005143.     CrossRef
  • The Role of Glycemic Control and Variability in Diabetic Retinopathy
    Irini P. Chatziralli
    Diabetes Therapy.2018; 9(1): 431.     CrossRef
  • Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
    Yeoree Yang, Eun-Young Lee, Jae-Hyoung Cho, Yong-Moon Park, Seung-Hyun Ko, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2018; 42(6): 496.     CrossRef
  • Verapamil is a potential therapy for hypoglycaemic brain injury
    Janice J. Hwang, Robert S. Sherwin
    Nature Reviews Endocrinology.2018; 14(8): 443.     CrossRef
  • The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment
    Julie T. Kloppenborg, Michael Gamborg, Cilius E. Fonvig, Tenna R. H. Nielsen, Oluf Pedersen, Jesper Johannesen, Torben Hansen, Jens‐Christian Holm
    Pediatric Diabetes.2018; 19(3): 366.     CrossRef
  • Increased glycemic variability in type 2 diabetes patients treated with insulin - a real-life clinical practice, continuous glucose monitoring (CGM) study
    Cristian-Ioan Crăciun, Anca-Elena Crăciun, Adriana Rusu, Corina Ioana Bocşan, Nicolae Hâncu, Anca Dana Buzoianu
    Revista Romana de Medicina de Laborator.2018; 26(3): 345.     CrossRef
  • Lixisenatide reduces glycaemic variability in insulin‐treated patients with type 2 diabetes
    Guillermo E. Umpierrez, David O'Neal, Andres DiGenio, Ronald Goldenberg, Eric Hernandez‐Triana, Jay Lin, Cheol‐Young Park, Eric Renard, Boris Kovatchev
    Diabetes, Obesity and Metabolism.2017; 19(9): 1317.     CrossRef
  • The relationship between fasting blood glucose variability and coronary artery collateral formation in type 2 diabetes patients with coronary artery disease
    Gang Cheng, Hilda Mahmoudi, Binna Chokshi, Marlena Fernandez, Vahid Kazemi, Nader Lamaa
    Coronary Artery Disease.2017; 28(6): 486.     CrossRef
  • How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?
    Ramzi A. Ajjan
    Diabetes Technology & Therapeutics.2017; 19(S2): S-27.     CrossRef
  • Effect of gemigliptin on glycaemic variability in patients with type 2 diabetes (STABLE study)
    Se E. Park, Byung W. Lee, Jae H. Kim, Woo J. Lee, Jae H. Cho, Chang H. Jung, Seung H. Lee, Sunghwan Suh, Gwong C. Hur, Sung H. Kim, Young H. Jang, Cheol Y. Park
    Diabetes, Obesity and Metabolism.2017; 19(6): 892.     CrossRef
  • Glucose variability indices predict the episodes of nocturnal hypoglycemia in elderly type 2 diabetic patients treated with insulin
    Vadim V. Klimontov, Natalia E. Myakina
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017; 11(2): 119.     CrossRef
  • A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes
    Ranjit Mohan Anjana, Jothydev Kesavadev, Deshpande Neeta, Mangesh Tiwaskar, Rajendra Pradeepa, Saravanan Jebarani, Suresh Thangamani, Nadiminty Ganapathi Sastry, Srivastava Brijendra Kumar, Muthu Ramu, Pokal Prasanna Kumar Gupta, Jayaprakash Vignesh, Sund
    Diabetes Technology & Therapeutics.2017; 19(9): 533.     CrossRef
  • Association Between Coronary Artery Calcification and the Hemoglobin Glycation Index: The Kangbuk Samsung Health Study
    Eun-Jung Rhee, Jung-Hwan Cho, Hyemi Kwon, Se Eun Park, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(12): 4634.     CrossRef
  • Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients
    Mei Uemura, Yutaka Yano, Toshinari Suzuki, Taro Yasuma, Toshiyuki Sato, Aya Morimoto, Samiko Hosoya, Chihiro Suminaka, Hiromu Nakajima, Esteban C. Gabazza, Yoshiyuki Takei
    Diabetes & Metabolism Journal.2017; 41(4): 265.     CrossRef
  • Glycemic Variability and Its Association With Demographics and Lifestyles in a General Adult Population
    Francisco Gude, Pablo Díaz-Vidal, Cintia Rúa-Pérez, Manuela Alonso-Sampedro, Carmen Fernández-Merino, Jesús Rey-García, Carmen Cadarso-Suárez, Marcos Pazos-Couselo, José Manuel García-López, Arturo Gonzalez-Quintela
    Journal of Diabetes Science and Technology.2017; 11(4): 780.     CrossRef
  • Glycaemic variability in patients with severe sepsis or septic shock admitted to an Intensive Care Unit
    L.M. Silveira, A. Basile-Filho, E.A. Nicolini, C.A.M. Dessotte, G.C.S. Aguiar, A.M. Stabile
    Intensive and Critical Care Nursing.2017; 41: 98.     CrossRef
  • Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled trial
    Juan P. Frías, Samer Nakhle, James A. Ruggles, Sergey Zhuplatov, Eric Klein, Rong Zhou, Poul Strange
    Diabetes, Obesity and Metabolism.2017; 19(1): 40.     CrossRef
  • Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus
    Markolf Hanefeld, Denis Raccah, Louis Monnier
    Expert Opinion on Drug Metabolism & Toxicology.2017; 13(3): 311.     CrossRef
  • Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
    Sunghwan Suh, Mi Kyoung Park
    Endocrinology and Metabolism.2017; 32(2): 180.     CrossRef
  • Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
    So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Eun Seok Kang, Bong-Soo Cha, Jeong-Ho Kim, Byung-Wan Lee
    Medicine.2016; 95(27): e4114.     CrossRef
  • Insulin degludec + liraglutide: a complementary combination
    K. Stinkens, B. Peene, C. Mathieu
    Expert Opinion on Biological Therapy.2016; 16(9): 1171.     CrossRef
  • GLP1-RA Add-on Therapy in Patients with Type 2 Diabetes Currently on a Bolus Containing Insulin Regimen
    Marie L. Davies, David Q. Pham, Scott R. Drab
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2016; 36(8): 893.     CrossRef
  • Teneligliptin: Heralding Change in Type 2 Diabetes
    Manish Maladkar, Srividya Sankar, Kushal Kamat
    Journal of Diabetes Mellitus.2016; 06(02): 113.     CrossRef
  • Association between estimated blood glucose levels and glycated hemoglobin levels
    Seon-Ah Cha, Seung-Hyun Ko
    The Korean Journal of Internal Medicine.2016; 31(3): 457.     CrossRef
  • Metformin attenuates fluctuating glucose-induced endothelial dysfunction through enhancing GTPCH1-mediated eNOS recoupling and inhibiting NADPH oxidase
    Huijie An, Rui Wei, Jing Ke, Jin Yang, Ye Liu, Xian Wang, Guang Wang, Tianpei Hong
    Journal of Diabetes and its Complications.2016; 30(6): 1017.     CrossRef
  • The impact of glycemic variability on diabetic peripheral neuropathy
    Heung Yong Jin, Kyung Ae Lee, Tae Sun Park
    Endocrine.2016; 53(3): 643.     CrossRef
  • The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus
    Won Seon Jeon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Cheol-Young Park
    Diabetes Research and Clinical Practice.2016; 116: 46.     CrossRef
  • Management of Steroid-induced Hyperglycemia
    Sunghwan Suh, Mi Kyoung Park
    The Journal of Korean Diabetes.2016; 17(3): 174.     CrossRef
  • Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study
    Jan Šoupal, Lenka Petruželková, Milan Flekač, Tomáš Pelcl, Martin Matoulek, Martina Daňková, Jan Škrha, Štěpán Svačina, Martin Prázný
    Diabetes Technology & Therapeutics.2016; 18(9): 532.     CrossRef
  • Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulin
    Vadim V. Klimontov, Natalia E. Myakina, Nadezda V. Tyan
    SpringerPlus.2016;[Epub]     CrossRef
Original Articles
Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database
Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
Diabetes Metab J. 2015;39(3):247-252.   Published online April 22, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.3.247
  • 4,438 View
  • 37 Download
  • 21 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   
Background

We assessed the association of dipeptidyl peptidase 4 inhibitors (DPP4i) with hospitalization for heart failure (HF) using the Korean Health Insurance claims database.

Methods

We collected data on newly prescribed sitagliptin, vildagliptin, and pioglitazone between January 1, 2009 and December 31, 2012 (mean follow-up of 336.8 days) to 935,519 patients with diabetes (518,614 males and 416,905 females) aged 40 to 79 years (mean age of 59.4 years).

Results

During the study, 998 patients were hospitalized for primary HF (115.7 per 100,000 patient-years). The incidence rate of hospitalization for HF was 117.7 per 100,000 per patient-years among patients on pioglitazone, 105.7 for sitagliptin, and 135.8 for vildagliptin. The hospitalization rate for HF was greatest in the first 30 days after starting the medication, which corresponded to a significantly higher incidence at days 0 to 30 compared with days 31 to 360 for all three drugs. The hazard ratios were 1.85 (pioglitazone), 2.00 (sitagliptin), and 1.79 (vildagliptin). The incidence of hospitalization for HF did not differ between the drugs for any time period.

Conclusion

This study showed an increase in hospitalization for HF in the initial 30 days of the DPP4i and pioglitazone compared with the subsequent follow-up period. However, the differences between the drugs were not significant.

Citations

Citations to this article as recorded by  
  • Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes
    Jui Wang, Hon-Yen Wu, Kuo-Liong Chien
    Diabetes & Metabolism.2022; 48(3): 101299.     CrossRef
  • Changing Fields-Diabetes Medications Invading the Cardiovascular Space
    Lauren D. Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P. Shah, Brandon E. Cave
    Current Problems in Cardiology.2021; 46(3): 100736.     CrossRef
  • Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2
    Srikanth Yandrapalli, Aaqib Malik, Adam Horblitt, Gayatri Pemmasani, Wilbert S. Aronow, William H. Frishman
    Cardiology in Review.2020; 28(5): 219.     CrossRef
  • Effects of antidiabetic drugs on left ventricular function/dysfunction: a systematic review and network meta-analysis
    Da-Peng Zhang, Li Xu, Le-Feng Wang, Hong-Jiang Wang, Feng Jiang
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
    Kyoung Jin Kim, Jimi Choi, Juneyoung Lee, Jae Hyun Bae, Jee Hyun An, Hee Young Kim, Hye Jin Yoo, Ji A. Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
    Cardiovascular Diabetology.2019;[Epub]     CrossRef
  • Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
    Kyoung Hwa Ha, Bongseong Kim, Hae Sol Shin, Jinhee Lee, Hansol Choi, Hyeon Chang Kim, Dae Jung Kim
    Korean Circulation Journal.2018; 48(5): 395.     CrossRef
  • Worsening Heart Failure During the Use of DPP-4 Inhibitors
    Milton Packer
    JACC: Heart Failure.2018; 6(6): 445.     CrossRef
  • Resistance exercise improves cardiac function and mitochondrial efficiency in diabetic rat hearts
    Tae Hee Ko, Jubert C. Marquez, Hyoung Kyu Kim, Seung Hun Jeong, SungRyul Lee, Jae Boum Youm, In Sung Song, Dae Yun Seo, Hye Jin Kim, Du Nam Won, Kyoung Im Cho, Mun Gi Choi, Byoung Doo Rhee, Kyung Soo Ko, Nari Kim, Jong Chul Won, Jin Han
    Pflügers Archiv - European Journal of Physiology.2018; 470(2): 263.     CrossRef
  • Do DPP-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically Mediated Cardiotoxicity?
    Milton Packer
    Circulation Research.2018; 122(7): 928.     CrossRef
  • Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes
    Hyouk-Jun Chin, Jin Hyun Nam, Eui-Kyung Lee, Ju-Young Shin
    Medicine.2017; 96(25): e7213.     CrossRef
  • Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction
    Nattayaporn Apaijai, Tharnwimol Inthachai, Suree Lekawanvijit, Siriporn C Chattipakorn, Nipon Chattipakorn
    Journal of Endocrinology.2016; 229(3): 245.     CrossRef
  • The current role of thiazolidinediones in diabetes management
    Christos V. Rizos, Anastazia Kei, Moses S. Elisaf
    Archives of Toxicology.2016; 90(8): 1861.     CrossRef
  • Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion
    Simón Quetzalcoatl Rodríguez-Lara, Ernesto German Cardona-Muñoz, Ernesto Javier Ramírez-Lizardo, Sylvia Elena Totsuka-Sutto, Araceli Castillo-Romero, Teresa Arcelia García-Cobián, Leonel García-Benavides, Kota V. Ramana
    Oxidative Medicine and Cellular Longevity.2016;[Epub]     CrossRef
  • Lessons learned from cardiovascular outcome clinical trials with dipeptidyl peptidase 4 (DPP-4) inhibitors
    Teresa Vanessa Fiorentino, Giorgio Sesti
    Endocrine.2016; 53(2): 373.     CrossRef
  • Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J2015;39:247-52)
    Dae Ho Lee
    Diabetes & Metabolism Journal.2015; 39(4): 348.     CrossRef
  • Response: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J2015;39:247-52)
    Sunghwan Suh, Gi Hyeon Seo, Chang Hee Jung, Mee-Kyoung Kim, Sang-Man Jin, You-Cheol Hwang, Byung-Wan Lee, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2015; 39(4): 350.     CrossRef
  • Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
    Mark M Smits, Lennart Tonneijck, Marcel H A Muskiet, Trynke Hoekstra, Mark H H Kramer, Indra C Pieters, Djuna L Cahen, Michaela Diamant, Daniël H van Raalte
    BMJ Open.2015; 5(11): e009579.     CrossRef
  • Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?
    Yong-ho Lee
    Diabetes & Metabolism Journal.2015; 39(3): 204.     CrossRef
A Randomized Controlled Trial of an Internet-Based Mentoring Program for Type 1 Diabetes Patients with Inadequate Glycemic Control
Sunghwan Suh, Cheol Jean, Mihyun Koo, Sun Young Lee, Min Ja Cho, Kang-Hee Sim, Sang-Man Jin, Ji Cheol Bae, Jae Hyeon Kim
Diabetes Metab J. 2014;38(2):134-142.   Published online April 18, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.2.134
  • 5,743 View
  • 56 Download
  • 22 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   
Background

To determine whether an internet-based mentoring program can improve glycemic control in subjects with type 1 diabetes mellitus (T1DM).

Methods

Subjects with T1DM on intensive insulin therapy and with hemoglobin A1c (HbA1c) ≥8.0% were randomized to mentored (glucometer transmission with feedback from mentors) or control (glucometer transmission without feedback) groups and were examined for 12 weeks. Five mentors were interviewed and selected, of which two were T1DM patients themselves and three were parents with at least one child diagnosed with T1DM since more than 5 years ago.

Results

A total of 57 T1DM adult subjects with a mean duration after being diagnosed with diabetes of 7.4 years were recruited from Samsung Medical Center. Unfortunately, the mentored group failed to show significant improvements in HbA1c levels or other outcomes, including the quality of life, after completion of the study. However, the mentored group monitored their blood glucose (1.41 vs. 0.30) and logged into our website (http://ubisens.co.kr/) more frequently (20.59 times vs. 5.07 times) than the control group.

Conclusion

A 12-week internet-based mentoring program for T1DM patients with inadequate glycemic control did not prove to be superior to the usual follow-up. However, the noted increase in the subjects' frequency of blood glucose monitoring may lead to clinical benefits.

Citations

Citations to this article as recorded by  
  • The Effectiveness of Telemedicine Solutions in Type 1 Diabetes Management: A Systematic Review and Meta-analysis
    Flemming Witt Udsen, Stine Hangaard, Clara Bender, Jonas Andersen, Thomas Kronborg, Peter Vestergaard, Ole Hejlesen, Sisse Laursen
    Journal of Diabetes Science and Technology.2023; 17(3): 782.     CrossRef
  • Quality improvement strategies for diabetes care: Effects on outcomes for adults living with diabetes
    Kristin J Konnyu, Sharlini Yogasingam, Johanie Lépine, Katrina Sullivan, Mostafa Alabousi, Alun Edwards, Michael Hillmer, Sathya Karunananthan, John N Lavis, Stefanie Linklater, Braden J Manns, David Moher, Sameh Mortazhejri, Samir Nazarali, P. Alison Pap
    Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef
  • Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
    Sejeong Lee, KyungYi Kim, Ji Eun Kim, Yura Hyun, Minyoung Lee, Myung-Il Hahm, Sang Gyu Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2023; 47(5): 693.     CrossRef
  • Evaluation of nurse‐led social media intervention for diabetes self‐management: A mixed‐method study
    Su Hyun Kim, Younghee Kim, Sookyung Choi, Bomin Jeon
    Journal of Nursing Scholarship.2022; 54(5): 569.     CrossRef
  • ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes in adolescence
    John W. Gregory, Fergus J. Cameron, Kriti Joshi, Mirjam Eiswirth, Christopher Garrett, Katharine Garvey, Shivani Agarwal, Ethel Codner
    Pediatric Diabetes.2022; 23(7): 857.     CrossRef
  • Diabetes Self-Management Education and Support to Improve Outcomes for Children and Young Adults With Type 1 Diabetes: An Umbrella Review of Systematic Reviews
    Latika Rohilla, Sukhpal Kaur, Mona Duggal, Prahbhjot Malhi, Bhavneet Bharti, Devi Dayal
    The Science of Diabetes Self-Management and Care.2021; 47(5): 332.     CrossRef
  • Smartphones and Apps to Control Glycosylated Hemoglobin (HbA1c) Level in Diabetes: A Systematic Review and Meta-Analysis
    María Begoña Martos-Cabrera, Almudena Velando-Soriano, Laura Pradas-Hernández, Nora Suleiman-Martos, Guillermo A. Cañadas-De la Fuente, Luis Albendín-García, José L. Gómez-Urquiza
    Journal of Clinical Medicine.2020; 9(3): 693.     CrossRef
  • Are We Ready to Treat Our Diabetes Patients Using Social Media? Yes, We Are
    Goran Petrovski, Marija Zivkovic
    Journal of Diabetes Science and Technology.2019; 13(2): 171.     CrossRef
  • Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials
    Huidi Tchero, Pauline Kangambega, Christine Briatte, Solenne Brunet-Houdard, Gerald-Reparate Retali, Emmanuel Rusch
    Telemedicine and e-Health.2019; 25(7): 569.     CrossRef
  • Distal technologies and type 1 diabetes management
    Danny C Duke, Samantha Barry, David V Wagner, Jane Speight, Pratik Choudhary, Michael A Harris
    The Lancet Diabetes & Endocrinology.2018; 6(2): 143.     CrossRef
  • Exploration of Users’ Perspectives and Needs and Design of a Type 1 Diabetes Management Mobile App: Mixed-Methods Study
    Yiyu Zhang, Xia Li, Shuoming Luo, Chaoyuan Liu, Fang Liu, Zhiguang Zhou
    JMIR mHealth and uHealth.2018; 6(9): e11400.     CrossRef
  • An information and communication technology-based centralized clinical trial to determine the efficacy and safety of insulin dose adjustment education based on a smartphone personal health record application: a randomized controlled trial
    Gyuri Kim, Ji Cheol Bae, Byoung Kee Yi, Kyu Yeon Hur, Dong Kyung Chang, Moon-Kyu Lee, Jae Hyeon Kim, Sang-Man Jin
    BMC Medical Informatics and Decision Making.2017;[Epub]     CrossRef
  • Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
    Shaun W. H. Lee, Leanne Ooi, Yin K. Lai
    Frontiers in Pharmacology.2017;[Epub]     CrossRef
  • Effects of consumer-oriented health information technologies in diabetes management over time: a systematic review and meta-analysis of randomized controlled trials
    Da Tao, Tieyan Wang, Tieshan Wang, Shuang Liu, Xingda Qu
    Journal of the American Medical Informatics Association.2017; 24(5): 1014.     CrossRef
  • Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China
    Hun-Sung Kim, Chenglin Sun, So Jung Yang, Lin Sun, Fei Li, In Young Choi, Jae-Hyoung Cho, Guixia Wang, Kun-Ho Yoon
    Telemedicine and e-Health.2016; 22(8): 666.     CrossRef
  • Does nutritional counseling in telemedicine improve treatment outcomes for diabetes? A systematic review and meta-analysis of results from 92 studies
    Dejun Su, Chelsea McBride, Junmin Zhou, Megan S Kelley
    Journal of Telemedicine and Telecare.2016; 22(6): 333.     CrossRef
  • Social Networking Services-Based Communicative Care for Patients with Diabetes Mellitus in Korea
    Hun-Sung Kim, Yoo Jeong, Sun Baik, So Yang, Tong Kim, Hyunah Kim, Hyunyong Lee, Seung-Hwan Lee, Jae Cho, In-Young Choi, Kun-Ho Yoon
    Applied Clinical Informatics.2016; 07(03): 899.     CrossRef
  • Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials
    Dejun Su, Junmin Zhou, Megan S. Kelley, Tzeyu L. Michaud, Mohammad Siahpush, Jungyoon Kim, Fernando Wilson, Jim P. Stimpson, José A. Pagán
    Diabetes Research and Clinical Practice.2016; 116: 136.     CrossRef
  • Adherence to Glycemic Monitoring in Diabetes
    Susana R. Patton
    Journal of Diabetes Science and Technology.2015; 9(3): 668.     CrossRef
  • Internet-Based Mentoring Program for Patients with Type 1 Diabetes
    Sun-Hye Ko, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2014; 38(2): 107.     CrossRef
Education as Prescription for Patients with Type 2 Diabetes Mellitus: Compliance and Efficacy in Clinical Practice
Mi Yeon Kim, Sunghwan Suh, Sang-Man Jin, Se Won Kim, Ji Cheol Bae, Kyu Yeon Hur, Sung Hye Kim, Mi Yong Rha, Young Yun Cho, Myung-Shik Lee, Moon Kyu Lee, Kwang-Won Kim, Jae Hyeon Kim
Diabetes Metab J. 2012;36(6):452-459.   Published online December 12, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.6.452
  • 4,948 View
  • 34 Download
  • 12 Crossref
AbstractAbstract PDFPubReader   
Background

Diabetes self-management education has an important role in diabetes management. The efficacy of education has been proven in several randomized trials. However, the status of diabetes education programs in real Korean clinical practice has not yet been evaluated in terms of patient compliance with the education prescription.

Methods

We retrospectively analyzed clinical and laboratory data from all patients who were ordered to undergo diabetes education during 2009 at Samsung Medical Center, Seoul, Korea (n=2,291). After excluding ineligible subjects, 588 patients were included in the analysis.

Results

Among the 588 patients, 433 received education. The overall compliance rate was 73.6%, which was significantly higher in the subjects with a short duration or living in a rural area compared to those with a long duration (85.0% vs. 65.1%, respectively; P<0.001) or living in an urban area (78.2% vs. 70.4%, respectively; P=0.037). The hemoglobin A1c decreased greater in the compliant group (from 7.84±1.54 at baseline to 6.79±1.06 at 3 months and 6.97±1.20 at 12 months after prescription in the compliant group vs. from 7.74±1.25 to 7.14±1.02 and 7.24±1.24 in the non-compliant group; P=0.001). The decrease in hemoglobin A1c was greater in the subjects with a short duration (P=0.032).

Conclusion

In our study a large percent of patients refuse to get education despite having a prescription from their physician. This refusal rate was higher in the patients with long-standing diabetes or in urban residence. Furthermore, education was more effective in patients with a short duration of diabetes in clinical practice.

Citations

Citations to this article as recorded by  
  • Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
    Sejeong Lee, KyungYi Kim, Ji Eun Kim, Yura Hyun, Minyoung Lee, Myung-Il Hahm, Sang Gyu Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2023; 47(5): 693.     CrossRef
  • Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
    Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
    The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
  • The Effectiveness of Multidisciplinary Team-Based Education in the Management of Type 2 Diabetes
    Jong Ho Kim, Yun Jeong Nam, Won Jin Kim, Kyung Ah Lee, A Ran Baek, Jung Nam Park, Jin Mi Kim, Seo Young Oh, Eun Heui Kim, Min Jin Lee, Yun Kyung Jeon, Bo Hyun Kim, In Joo Kim, Yong Ki Kim, Sang Soo Kim
    The Journal of Korean Diabetes.2018; 19(2): 119.     CrossRef
  • The diabetes self-management educational programs and their integration in the usual care: A systematic literature review
    Emmanuel Kumah, Giulia Sciolli, Maria Laura Toraldo, Anna Maria Murante
    Health Policy.2018; 122(8): 866.     CrossRef
  • Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus
    So Young Park, Sun Young Kim, Hye Mi Lee, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Kang-Hee Sim, Sang-Man Jin
    Diabetes & Metabolism Journal.2017; 41(2): 99.     CrossRef
  • Educational attainment moderates the associations of diabetes education with health outcomes
    Su Hyun Kim
    International Journal of Nursing Practice.2016; 22(5): 444.     CrossRef
  • Experiences of Diabetes Education among Educators of Diabetes : a content analysis approach
    Soo Jin Kang, Soo Jung Chang
    Journal of Korean Public Health Nursing.2016; 30(2): 221.     CrossRef
  • Barrier Factors to the Completion of Diabetes Education in Korean Diabetic Adult Patients: Korea National Health and Nutrition Examination Surveys 2007-2012
    Hee-Tae Kim, Kiheon Lee, Se Young Jung, Seung-Min Oh, Su-Min Jeong, Yoon-Jung Choi
    Korean Journal of Family Medicine.2015; 36(5): 203.     CrossRef
  • Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study)
    C. McAdam‐Marx, B. K. Bellows, S. Unni, J. Mukherjee, G. Wygant, U. Iloeje, J. N. Liberman, X. Ye, F. J. Bloom, D. I. Brixner
    International Journal of Clinical Practice.2014; 68(11): 1309.     CrossRef
  • Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: A systematic review and meta-analysis
    Mohsen Saffari, Ghader Ghanizadeh, Harold G. Koenig
    Primary Care Diabetes.2014; 8(4): 275.     CrossRef
  • The Appropriateness of the Length of Insulin Needles Based on Determination of Skin and Subcutaneous Fat Thickness in the Abdomen and Upper Arm in Patients with Type 2 Diabetes
    Kang Hee Sim, Moon Sook Hwang, Sun Young Kim, Hye Mi Lee, Ji Yeun Chang, Moon Kyu Lee
    Diabetes & Metabolism Journal.2014; 38(2): 120.     CrossRef
  • Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross‐national benchmarking of diabetes‐related psychosocial outcomes for people with diabetes
    A. Nicolucci, K. Kovacs Burns, R. I. G. Holt, M. Comaschi, N. Hermanns, H. Ishii, A. Kokoszka, F. Pouwer, S. E. Skovlund, H. Stuckey, I. Tarkun, M. Vallis, J. Wens, M. Peyrot
    Diabetic Medicine.2013; 30(7): 767.     CrossRef
Cardio-Metabolic Features of Type 2 Diabetes Subjects Discordant in the Diagnosis of Metabolic Syndrome
Sa Rah Lee, Ying Han, Ja Won Kim, Ja Young Park, Ji Min Kim, Sunghwan Suh, Mi-Kyoung Park, Hye-Jeong Lee, Duk Kyu Kim
Diabetes Metab J. 2012;36(5):357-363.   Published online October 18, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.5.357
  • 3,923 View
  • 29 Download
  • 3 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study is to investigate the cardio-metabolic parameters and surrogate markers of insulin resistance in a discordant group of type 2 diabetes (T2DM) subjects who satisfy the Adults Treatment Panel (ATP) III criteria, but not the International Diabetes Federation (IDF) criteria, for metabolic syndrome (MetS).

Methods

We assessed the prevalence of MetS in T2DM subjects (n=167) who were selected from subjects registered at the diabetes center of Dong-A University Medical Center. We used the ATP III criteria and the IDF criteria for the diagnosis of MetS and sorted the subjects into 2 MetS groups: one group diagnosed per ATP III criteria (MetSa) and one diagnosed per IDF criteria (MetSi). We then compared the clinical characteristics, metabolic parameters (homeostasis model assessment of insulin resistance, aspartate aminotransferase, alanine aminotransferase, and uric acid values) and co-morbidities (prevalence of microalbuminuria, fatty liver, and cardiovascular disease) between the MetSa, MetSi, and discordant MetS groups.

Results

The prevalence of MetS in the MetSa group (73.6%) was higher than in the MetSi group (62.2%). The MetS prevalence in the discordant group was 11.4%. The discordant group showed no significant differences in clinical characteristics (except waist circumference and body mass index), metabolic parameters, or prevalence of co-morbidities, as compared with subjects with MetS by both criteria.

Conclusion

In this study, cardio-metabolic features of the subjects diagnosed with MetS using ATP III criteria, but not IDF criteria, are not significantly different from those of subjects diagnosed with MetS using both criteria.

Citations

Citations to this article as recorded by  
  • Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly
    Ping Liu, Shujian Sui, Dongling Xu, Xiaowei Xing, Caixia Liu
    Revista Portuguesa de Cardiologia.2014; 33(7-8): 411.     CrossRef
  • Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
    Tae Woo Jung, Hwan-Jin Hwang, Ho Cheol Hong, Hae Yoon Choi, Hye Jin Yoo, Sei Hyun Baik, Kyung Mook Choi
    Molecular and Cellular Endocrinology.2014; 391(1-2): 30.     CrossRef
  • Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly
    Ping Liu, Shujian Sui, Dongling Xu, Xiaowei Xing, Caixia Liu
    Revista Portuguesa de Cardiologia (English Edition).2014; 33(7-8): 411.     CrossRef
Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients
Sunghwan Suh, Hyung-Doo Park, Se Won Kim, Ji Cheol Bae, Alice Hyun-Kyung Tan, Hye Soo Chung, Kyu Yeon Hur, Jae Hyeon Kim, Kwang-Won Kim, Moon-Kyu Lee
Diabetes Metab J. 2011;35(5):536-542.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.536
  • 5,499 View
  • 49 Download
  • 15 Crossref
AbstractAbstract PDFPubReader   
Background

Small dense low density lipoprotein (sdLDL) has recently emerged as an important risk factor of coronary heart disease.

Methods

The mean LDL particle size was measured in 203 patients with type 2 diabetes mellitus (T2DM) and 212 matched subjects without diabetes using polyacrylamide tube gel electrophoresis. Major vascular complications were defined as stroke, angiographically-documented coronary artery disease or a myocardial infarction. Peripheral vascular stenosis, carotid artery stenosis (≥50% in diameter) or carotid artery plaque were considered minor vascular complications. Overall vascular complications included both major and minor vascular complications.

Results

Diabetic patients had significantly smaller mean-LDL particle size (26.32 nm vs. 26.49 nm) and a higher percentage of sdLDL to total LDL compared to those of subjects without diabetes (21.39% vs. 6.34%). The independent predictors of sdLDL in this study were serum triglyceride level and body mass index (odds ratio [OR], 1.020 with P<0.001 and OR 1.152 with P<0.027, respectively). However, no significant correlations were found between sdLDL and major vascular complications (P=0.342), minor vascular complications (P=0.573) or overall vascular complications (P=0.262) in diabetic subjects.

Conclusion

Diabetic patients had a smaller mean-LDL particle size and higher proportion of sdLDL compared to those of subjects without diabetes. Obese diabetic patients with hypertriglyceridemia have an increased risk for atherogenic small dense LDL. However, we could not verify an association between LDL particle size and vascular complications in this study.

Citations

Citations to this article as recorded by  
  • Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome
    Sara Deza, Inmaculada Colina, Oscar Beloqui, José Ignacio Monreal, Estéfani Martínez-Chávez, Julia Maroto-García, Carmen Mugueta, Alvaro González, Nerea Varo
    Clinica Chimica Acta.2024; 557: 117897.     CrossRef
  • Nrf2 Signaling Pathway as a Key to Treatment for Diabetic Dyslipidemia and Atherosclerosis
    Michelle Yi, Arvin John Toribio, Yusuf Muhammad Salem, Michael Alexander, Antoney Ferrey, Lourdes Swentek, Ekamol Tantisattamo, Hirohito Ichii
    International Journal of Molecular Sciences.2024; 25(11): 5831.     CrossRef
  • Association between measured or calculated small dense low‐density lipoprotein cholesterol and oxidized low‐density lipoprotein in subjects with or without type 2 diabetes mellitus
    Hyun‐Ki Kim, Jinyoung Hong, Sunyoung Ahn, Woochang Lee, Sail Chun, Won‐Ki Min
    Journal of Clinical Laboratory Analysis.2023;[Epub]     CrossRef
  • The association of apolipoprotein in the risk of ST-elevation myocardial infarction in patients with documented coronary artery disease
    Astuti Giantini, Nur Gifarani Pratiwi, Renan Sukmawan, Joedo Prihartono, Suzanna Immanuel, Merci Monica Pasaribu, Sri Suryo Adiyanti, Yusuf Bahasoan
    International Journal of Cardiology Cardiovascular Risk and Prevention.2023; 18: 200194.     CrossRef
  • Atherogenic Index of Plasma and Its Association with Risk Factors of Coronary Artery Disease and Nutrient Intake in Korean Adult Men: The 2013–2014 KNHANES
    Hye Ran Shin, SuJin Song, Jin Ah Cho, Sun Yung Ly
    Nutrients.2022; 14(5): 1071.     CrossRef
  • The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes
    Kuo Zhou, Zheng Qin, Jinfan Tian, Kongyong Cui, Yunfeng Yan, Shuzheng Lyu
    Angiology.2021; 72(10): 934.     CrossRef
  • Direct bilirubin is associated with low-density lipoprotein subfractions and particle size in overweight and centrally obese women
    Y.-J. Kwon, H.-S. Lee, J.-W. Lee
    Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(10): 1021.     CrossRef
  • Correlation between Cholesterol, Triglycerides, Calculated, and Measured Lipoproteins: Whether Calculated Small Density Lipoprotein Fraction Predicts Cardiovascular Risks
    Sikandar Hayat Khan, Nadeem Fazal, Athar Abbas Gilani Shah, Syed Mohsin Manzoor, Naveed Asif, Aamir Ijaz, Najmusaqib Khan Niazi, Muhammad Yasir
    Journal of Lipids.2017; 2017: 1.     CrossRef
  • Effects of Small Dense LDL in Diabetic Nephropathy in Females with Type 2 Diabetes Mellitus
    Seongyul Ryu, Youngwoo Kim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Hyun Baek, Ki-Ho Song, Kyung-Jin Yun
    Journal of Lipid and Atherosclerosis.2016; 5(1): 11.     CrossRef
  • Prepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes
    Emily S. Han, Ronald M. Krauss, Fei Xu, Sneha B. Sridhar, Assiamira Ferrara, Charles P. Quesenberry, Monique M. Hedderson
    The Journal of Clinical Endocrinology & Metabolism.2016; 101(7): 2721.     CrossRef
  • Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus
    Xiao-Wei Zhu, Fei-Yan Deng, Shu-Feng Lei
    Primary Care Diabetes.2015; 9(1): 60.     CrossRef
  • Higher levels of small dense low‐density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
    E.‐H. Jang, Y.‐M. Park, J. Hur, M.‐K. Kim, S.‐H. Ko, K.‐H. Baek, K.‐H. Song, K.‐W. Lee, H.‐S. Kwon
    Diabetic Medicine.2013; 30(6): 694.     CrossRef
  • Sleep Status and Low-Density Lipoprotein Particle Size in a General Japanese Female Population: The Mima Study
    Kazuhiko Kotani, Kokoro Tsuzaki, Shinji Fujiwara, Naoki Sakane
    Medical Principles and Practice.2013; 22(5): 510.     CrossRef
  • Serum small-dense LDL abnormalities in chronic renal disease patients
    M. Chu, A. Y. M. Wang, I. H. S. Chan, S. H. Chui, C. W. K. Lam
    British Journal of Biomedical Science.2012; 69(3): 99.     CrossRef
  • Small Dense Low-density Lipoprotein and Cardiovascular Disease
    Sunghwan Suh, Moon-Kyu Lee
    Journal of Lipid and Atherosclerosis.2012; 1(1): 1.     CrossRef
Effects of Resistance Training and Aerobic Exercise on Insulin Sensitivity in Overweight Korean Adolescents: A Controlled Randomized Trial
Sunghwan Suh, In-Kyong Jeong, Mi Yeon Kim, Yeon Soo Kim, Sue Shin, Sun Sin Kim, Jae Hyeon Kim
Diabetes Metab J. 2011;35(4):418-426.   Published online August 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.4.418
  • 22,186 View
  • 58 Download
  • 23 Crossref
AbstractAbstract PDFPubReader   
Background

Data on the impact of resistance training on insulin resistance in overweight or obese children are inconclusive.

Methods

Thirty overweight South Korean adolescents (mean age of 13.10 years) were divided by sex, and then randomly assigned to one of three treatment groups, which were the diet only (DO), diet with aerobic exercise (AE), or diet with resistance training (RT) group. Physiologic and metabolic parameters were assessed at baseline and after 12 weeks of exercise training and diet modification.

Results

Both exercise groups (aerobic and resistance) showed significant improvements in their insulin area under the curve and insulin sensitivity index values when compared to their baseline values while the DO group showed no significant changes in these variables. Age-, sex-, and body mass index (BMI)-adjusted intergroup comparison analyses showed a marked reduction in BMI and a significant reduction in muscle mass in the AE group when compared to the RT group and the DO group, respectively.

Conclusion

A 12-week exercise training program of either resistance or aerobic activity improved insulin sensitivity in overweight adolescents, although it failed to show superiority over a DO program. Aerobic exercise decreased both body weight and BMI, and it was noted that this group also had a significant reduction in muscle mass when compared to the DO group.

Citations

Citations to this article as recorded by  
  • Effect of high-intensity interval training and moderate-intensity continuous training on cardiovascular risk factors in adolescents: Systematic review and meta-analysis of randomized controlled trials
    Ya Wang, Shun Wang, Xiangwu Meng, Husheng Zhou
    Physiology & Behavior.2024; 275: 114459.     CrossRef
  • Exploring molecular mechanisms of exercise on metabolic syndrome: a bibliometric and visualization study using CiteSpace
    Kang Wan, Yue Jin, Ruobing Fan, Qizi Xu, Xiaoshi Li, Hongmei Yan, Ru Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Exercise and Nutrition Strategies for Combating Sarcopenia and Type 2 Diabetes Mellitus in Older Adults
    Dionysia Argyropoulou, Nikolaos D. Geladas, Tzortzis Nomikos, Vassilis Paschalis
    Journal of Functional Morphology and Kinesiology.2022; 7(2): 48.     CrossRef
  • Effects and dose-response relationships of exercise intervention on weight loss in overweight and obese children: a meta-regression and system review
    Rui Xu, Qiao-Ting Huang, Yu-Ting Chen, Peng-Yin Wang
    Journal of Pediatric Endocrinology and Metabolism.2022; 35(9): 1117.     CrossRef
  • The Benefits of Resistance Training in Obese Adolescents: A Systematic Review and Meta-analysis
    Bruno Ribeiro, Pedro Forte, Raquel Vinhas, Daniel A. Marinho, Luís B. Faíl, Ana Pereira, Fernando Vieira, Henrique P. Neiva
    Sports Medicine - Open.2022;[Epub]     CrossRef
  • Effects of Eight Weeks of Combined Training with Antioxidant Vitamins E and C on Glutathione, Glutathione Peroxidase, and Superoxide Dismutase in the Heart Tissue of Streptozotocin-induced Diabetic Rats
    Elaheh Heydarnia, Farzaneh Taghian, Khosro Jalali Dehkodi, Mehrzad Moghadasi
    Gene, Cell and Tissue.2021;[Epub]     CrossRef
  • Effect of resistance training with and without caloric restriction on visceral fat: A systemic review and meta‐analysis
    Mousa Khalafi, Abbas Malandish, Sara K. Rosenkranz, Ali A. Ravasi
    Obesity Reviews.2021;[Epub]     CrossRef
  • IMPACT OF TREADMILL RUNNING ON BLOOD GLUCOSE LEVEL OF TYPE 2 DIABETES MELLITUS PATIENTS IN GHURKI TRUST AND TEACHING HOSPITAL
    Samiya Noreen, Muhammad Shafique, Tayyaba Mustafa Mian, Hafiz Abdul Rehman, Abdul Rehman, Muhammad Saad Shafiq, Ibraheem Zafar, Ramsha Masood
    Pakistan BioMedical Journal.2021;[Epub]     CrossRef
  • Role of exercise on insulin sensitivity and beta-cell function: is exercise sufficient for the prevention of youth-onset type 2 diabetes?
    Joon Young Kim, Justin Y. Jeon
    Annals of Pediatric Endocrinology & Metabolism.2020; 25(4): 208.     CrossRef
  • Effects of HIIT and MICT on cardiovascular risk factors in adults with overweight and/or obesity: A meta-analysis
    LiQiang Su, JinMei Fu, ShunLi Sun, GuangGao Zhao, Wei Cheng, ChuanChuan Dou, MingHui Quan, Belinda Parmenter
    PLOS ONE.2019; 14(1): e0210644.     CrossRef
  • What Is the Role of Resistance Exercise in Improving the Cardiometabolic Health of Adolescents with Obesity?
    SoJung Lee, YoonMyung Kim, Jennifer L. Kuk
    Journal of Obesity & Metabolic Syndrome.2019; 28(2): 76.     CrossRef
  • Does exercise training affect resting metabolic rate in adolescents with obesity?
    Angela S. Alberga, Denis Prud’homme, Ronald J. Sigal, Gary S. Goldfield, Stasia Hadjiyannakis, Réjeanne Gougeon, Penny Phillips, Janine Malcolm, George A. Wells, Steve Doucette, Jinhui Ma, Glen P. Kenny
    Applied Physiology, Nutrition, and Metabolism.2017; 42(1): 15.     CrossRef
  • Iniciación al entrenamiento de fuerza en edades tempranas: revisión
    G. Peña, J.R. Heredia, C. Lloret, M. Martín, M.E. Da Silva-Grigoletto
    Revista Andaluza de Medicina del Deporte.2016; 9(1): 41.     CrossRef
  • Effects of aerobic training, resistance training, or both on cardiorespiratory and musculoskeletal fitness in adolescents with obesity: the HEARTY trial
    Angela S. Alberga, Denis Prud’homme, Ronald J. Sigal, Gary S. Goldfield, Stasia Hadjiyannakis, Penny Phillips, Janine Malcolm, Jinhui Ma, Steve Doucette, Rejeanne Gougeon, George A. Wells, Glen P. Kenny
    Applied Physiology, Nutrition, and Metabolism.2016; 41(3): 255.     CrossRef
  • The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity
    Farzad Zehsaz, Negin Farhangi, Mehri Ghahramani
    The Physician and Sportsmedicine.2016; 44(4): 355.     CrossRef
  • Epidemiology of Childhood Obesity in Korea
    Kyoung Hwa Ha, Dae Jung Kim
    Endocrinology and Metabolism.2016; 31(4): 510.     CrossRef
  • Muscle strength in youth and cardiovascular risk in young adulthood (the European Youth Heart Study)
    Anders Grøntved, Mathias Ried-Larsen, Niels Christian Møller, Peter Lund Kristensen, Karsten Froberg, Søren Brage, Lars Bo Andersen
    British Journal of Sports Medicine.2015; 49(2): 90.     CrossRef
  • Position statement on youth resistance training: the 2014 International Consensus
    Rhodri S Lloyd, Avery D Faigenbaum, Michael H Stone, Jon L Oliver, Ian Jeffreys, Jeremy A Moody, Clive Brewer, Kyle C Pierce, Teri M McCambridge, Rick Howard, Lee Herrington, Brian Hainline, Lyle J Micheli, Rod Jaques, William J Kraemer, Michael G McBride
    British Journal of Sports Medicine.2014; 48(7): 498.     CrossRef
  • Abdominal obesity and low physical activity are associated with insulin resistance in overweight adolescents: a cross-sectional study
    Claudia-María Velásquez-Rodríguez, Marcela Velásquez-Villa, Leidy Gómez-Ocampo, Juliana Bermúdez-Cardona
    BMC Pediatrics.2014;[Epub]     CrossRef
  • Exercise and Insulin Resistance in Youth: A Meta-Analysis
    Michael V. Fedewa, Nicholas H. Gist, Ellen M. Evans, Rod K. Dishman
    Pediatrics.2014; 133(1): e163.     CrossRef
  • What is the Effect of Resistance Training on the Strength, Body Composition and Psychosocial Status of Overweight and Obese Children and Adolescents? A Systematic Review and Meta-Analysis
    Natasha Schranz, Grant Tomkinson, Tim Olds
    Sports Medicine.2013; 43(9): 893.     CrossRef
  • A Review of Randomized Controlled Trials of Aerobic Exercise Training on Fitness and Cardiometabolic Risk Factors in Obese Adolescents
    A. S. Alberga, A. Frappier, R. J. Sigal, D. Prud'homme, G. P. Kenny
    The Physician and Sportsmedicine.2013; 41(2): 44.     CrossRef
  • Effects of Aerobic Versus Resistance Exercise Without Caloric Restriction on Abdominal Fat, Intrahepatic Lipid, and Insulin Sensitivity in Obese Adolescent Boys
    SoJung Lee, Fida Bacha, Tamara Hannon, Jennifer L. Kuk, Chris Boesch, Silva Arslanian
    Diabetes.2012; 61(11): 2787.     CrossRef
Review
Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
Sunghwan Suh, Kwang-Won Kim
Diabetes Metab J. 2011;35(3):193-198.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.193
  • 5,189 View
  • 43 Download
  • 83 Crossref
AbstractAbstract PDFPubReader   

Diabetes mellitus is a serious and growing health problem worldwide and is associated with severe acute and chronic complications. Moreover, epidemiologic evidence suggests that people with diabetes are at significantly higher risk for many forms of cancer. Several studies indicate an association between diabetes and the risk of liver, pancreas, endometrium, colon/rectum, breast, and bladder cancer. Mortality is also moderately increased in subjects with diabetes. Common risk factors such as age, obesity, physical inactivity and smoking may contribute to increased cancer risk in diabetic patients. Hyperinsulinemia most likely favors cancer in diabetic patients as insulin is a growth factor with pre-eminent metabolic as well as mitogenic effects, and its action in malignant cells is favored by mechanisms acting at both the receptor and post-receptor level. The effect of diabetes treatment drugs, aside from metformin, on cancer is not conclusive. In order to fight the perfect storm of diabetes and cancer, strategies to promote primary prevention and early detection of these conditions are urgently needed.

Citations

Citations to this article as recorded by  
  • Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells
    Eun-Bin Kim, Hye-Yoon Jeon, Yung-Taek Ouh, Ah-Jun Lee, Chan-Hee Moon, Sung Hun Na, Kwon-Soo Ha
    Biomedicine & Pharmacotherapy.2024; 172: 116232.     CrossRef
  • Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis
    So Yon Jun, Sooyoung Cho, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung Yong Jeong, Kyu Joo Park, Aesun Shin
    Cancer Medicine.2024;[Epub]     CrossRef
  • Mitochondrial ALDH2 improves ß‐cell survival and function against doxorubicin‐induced apoptosis by targeting CK2 signaling
    Udayakumar Karunakaran, Eun Yeong Ha, Suma Elumalai, Kyu Chang Won, Jun Sung Moon
    Journal of Diabetes Investigation.2024; 15(6): 684.     CrossRef
  • The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Long-Shan Yang, Lun-Jie Yan, Guang-Xiao Meng, Zi-Niu Ding, Sheng-Yu Yao, Hai-Chao Li, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
    Nutrition and Cancer.2023; 75(2): 461.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Care in Diabetes—2023
    Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lo
    Diabetes Care.2023; 46(Supplement): s49.     CrossRef
  • TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population
    Anca Florentina Mitroi, Nicoleta Leopa, Eugen Dumitru, Andrei Dumitru, Cristina Tocia, Ioana Popescu, Adrian Mitroi, Răzvan Cătălin Popescu
    Medicine.2023; 102(7): e33056.     CrossRef
  • New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents
    Ulviye Acar Çevik, Ismail Celik, Leyla Paşayeva, Hanifa Fatullayev, Hayrani E. Bostancı, Yusuf Özkay, Zafer A. Kaplancıklı
    Archiv der Pharmazie.2023;[Epub]     CrossRef
  • Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives
    Muhammad Nawaz, Muhammad Taha, Faiza Qureshi, Nisar Ullah, Manikandan Selvaraj, Sumaira Shahzad, Sridevi Chigurupati, Samar A. Abubshait, Tauqir Ahmad, Sampath Chinnam, Soleiman Hisaindee
    Journal of Biomolecular Structure and Dynamics.2022; 40(21): 10730.     CrossRef
  • Association between Alzheimer's disease and risk of cancer: A retrospective cohort study in Shanghai, China
    Ru‐Jing Ren, Qiang Huang, Gang Xu, Kai Gu, Eric B. Dammer, Chun‐Fang Wang, Xin‐Yi Xie, Wen Chen, Zhen‐Yi Shao, Sheng‐Di Chen, Gang Wang
    Alzheimer's & Dementia.2022; 18(5): 924.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

    Diabetes Care.2022; 45(Supplement): S46.     CrossRef
  • A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer
    Qiongyu Hao, Zhimin Huang, Qun Li, Dingxie Liu, Piwen Wang, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Ke Wu, Rui Su, Zhongmin Liu, Jay Vadgama, Yong Wu
    Advanced Science.2022;[Epub]     CrossRef
  • Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target
    María Garranzo-Asensio, Guillermo Solís-Fernández, Ana Montero-Calle, José Manuel García-Martínez, Maria Carmen Fiuza, Pilar Pallares, Nuria Palacios-Garcia, Custodia García-Jiménez, Ana Guzman-Aranguez, Rodrigo Barderas
    Diabetes.2022; 71(3): 497.     CrossRef
  • Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals
    Chandrakala Aluganti Narasimhulu, Dinender K. Singla
    Canadian Journal of Physiology and Pharmacology.2022; 100(5): 441.     CrossRef
  • Sleep Disruption and Cancer: Chicken or the Egg?
    Adrian Berisha, Kyle Shutkind, Jeremy C. Borniger
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • A comparative study of phytochemical, antioxidant, anticarcinogenic, and antidiabetic potential of coriander (Coriandrum sativum L.): Microgreen and mature plant
    G. M. Dhakshayani, S. Janaki Alias Priya
    Foods and Raw Materials.2022; : 283.     CrossRef
  • Influence of type II diabetes mellitus on postoperative complications following colorectal cancer surgery
    Răzvan Cătălin Popescu, Nicoleta Leopa, Eugen Dumitru, Anca Mitroi, Cristina Tocia, Andrei Dumitru, Costel Brînzan, Florin Botea
    Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
  • Diabetes Mellitus as a Risk Factor for Different Types of Cancers: A Systematic Review
    Saud S Alharbi
    Clinical Cancer Investigation Journal.2022; 11(4): 19.     CrossRef
  • Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
    Fausto Petrelli, Michele Ghidini, Emanuele Rausa, Antonio Ghidini, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Maria Chiara Parati, Filippo Pietrantonio, Paolo Sganzerla, Antonio Carlo Bossi
    Canadian Journal of Diabetes.2021; 45(2): 186.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

    Diabetes Care.2021; 44(Supplement): S40.     CrossRef
  • High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
    Unchalee Thonsri, Sopit Wongkham, Chaisiri Wongkham, Shinjiro Hino, Mitsuyoshi Nakao, Sittiruk Roytrakul, Tomoaki Koga, Wunchana Seubwai
    Cancer Science.2021; 112(1): 254.     CrossRef
  • On the meaning of and relationship between dragon-kings, black swans and related concepts
    Ingrid Glette-Iversen, Terje Aven
    Reliability Engineering & System Safety.2021; 211: 107625.     CrossRef
  • Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
    Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong
    Hepatology Communications.2021; 5(7): 1212.     CrossRef
  • Metabolic profiling analysis for clinical urine of colorectal cancer
    Wu Ning, Nan Qiao, Xiyin Zhang, Dongpo Pei, Wenyue Wang
    Asia-Pacific Journal of Clinical Oncology.2021; 17(4): 403.     CrossRef
  • Metformin suppresses breast cancer growth via inhibition of cyclooxygenase‑2
    Bin Shi, Xinyu Hu, Huimin He, Wenzheng Fang
    Oncology Letters.2021;[Epub]     CrossRef
  • Characteristics that influence the diagnosis and treatment of diabetes in geriatric patients over 75
    Angelo Scuteri
    Journal of Gerontology and Geriatrics.2021; 69(4): 238.     CrossRef
  • Need of integrated management of type ii diabetes mellitus as a serious risk factor in modifying outcomes in cancer management: A literature review
    YogeshNarayan Bendale, Vineeta Bendale, Pravin Gund, Avinash Kadam
    INDIAN JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE KLEU.2021; 2(2): 50.     CrossRef
  • Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort
    Ye-Seul Kim, Eun-A. Choi, Jae-woo Lee, Yonghwan Kim, Hyo-Sun You, Ye-Eun Han, Hyeong-Seop Kim, Yoon-Jong Bae, Hee-Taik Kang, Joungyoun Kim
    Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1714.     CrossRef
  • No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
    Jelle Evers, Anne J. Grotenhuis, Katja K. H. Aben, Lambertus A. L. M. Kiemeney, Alina Vrieling, Ernest K. Amankwah
    PLOS ONE.2020; 15(3): e0229384.     CrossRef
  • Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population
    Anastasios Tentolouris, Ioanna Eleftheriadou, Kostas Athanasakis, John Kyriopoulos, Diamantis I. Tsilimigras, Pinelopi Grigoropoulou, John Doupis, Nikolaos Tentolouris
    Hellenic Journal of Cardiology.2020; 61(1): 15.     CrossRef
  • A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
    Lu-Huai Feng, Tingting Su, Kun-Peng Bu, Shuang Ren, Zhenhua Yang, Cheng-En Deng, Bi-Xun Li, Wei-Yuan Wei
    Scientific Reports.2020;[Epub]     CrossRef
  • Cohort Profile: The Maule Cohort (MAUCO)
    Catterina Ferreccio, Andrea Huidobro, Sandra Cortés, Claudia Bambs, Pablo Toro, Vanessa Van De Wyngard, Johanna Acevedo, Fabio Paredes, Pía Venegas, Hugo Verdejo, Ximena Oyarzún-González, Paz Cook, Pablo F Castro, Claudia Foerster, Claudio Vargas, Jill Ko
    International Journal of Epidemiology.2020; 49(3): 760.     CrossRef
  • Gastric Cancer Heterogeneity and Clinical Outcomes
    Rachel E. Sexton, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Maria Diab, Asfar S. Azmi
    Technology in Cancer Research & Treatment.2020; 19: 153303382093547.     CrossRef
  • Temporal trajectories of accompanying comorbidities in patients with type 2 diabetes: a Korean nationwide observational study
    Eugene Jeong, Namgi Park, Yujeong Kim, Ja Young Jeon, Wou Young Chung, Dukyong Yoon
    Scientific Reports.2020;[Epub]     CrossRef
  • Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer
    Wedad Saeed Al-Qahtani, Ebtesam Al-Olayan, Fatimah Gh. Albani, Rania Saad Suliman, Nada Hamad Aljarba, E.M. Al-Humaidhi, Alanood S. Almurshedi, Dalia Mostafa Domiaty, Manal Abdullah Alduwish, Aljohara M. Al-Otaibi, Abdelbaset Mohamed Elasbali, Hussain Gad
    Global Medical Genetics.2020; 07(02): 035.     CrossRef
  • Glycation Leads to Increased Polysialylation and Promotes the Metastatic Potential of Neuroblastoma Cells
    Maximilian Scheer, Kaya Bork, Frieder Simon, Manimozhi Nagasundaram, Rüdiger Horstkorte, Vinayaga Srinivasan Gnanapragassam
    Cells.2020; 9(4): 868.     CrossRef
  • Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
    Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
    The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
  • Synthesis, α-glucosidase inhibition and antioxidant activity of the 7-carbo–substituted 5-bromo-3-methylindazoles
    Malose J. Mphahlele, Nontokozo M. Magwaza, Samantha Gildenhuys, Itumeleng B. Setshedi
    Bioorganic Chemistry.2020; 97: 103702.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

    Diabetes Care.2020; 43(Supplement): S37.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Medical Care in Diabetes—2019

    Diabetes Care.2019; 42(Supplement): S34.     CrossRef
  • Diabetes‐mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
    Laura Del Puerto‐Nevado, Aranzazu Santiago‐Hernandez, Sonia Solanes‐Casado, Nieves Gonzalez, Marta Ricote, Marta Corton, Isabel Prieto, Sebastian Mas, Ana Belen Sanz, Oscar Aguilera, Carmen Gomez‐Guerrero, Carmen Ayuso, Alberto Ortiz, Federico Rojo, Jesus
    Molecular Oncology.2019; 13(9): 1887.     CrossRef
  • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
    Sunghwan Suh, Kwang-Won Kim
    Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
  • Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis
    Hai Zeng, Meng Luo, Zunjiang Li, Junru Wen, Guoxin He, Yuelin Jin, Wenbin Fu, Peng Zhou
    BMJ Open.2019; 9(7): e029426.     CrossRef
  • Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome
    Ana P. Santos, Clara Castro, Luís Antunes, Rui Henrique, M. Helena Cardoso, Mariana P. Monteiro
    Journal of Clinical Medicine.2019; 8(9): 1479.     CrossRef
  • Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
    Yi-Chun Kuan, Kuang-Wei Huang, Cheng-Li Lin, Jiing-Chyuan Luo, Chia-Hung Kao
    Cancers.2019; 11(10): 1468.     CrossRef
  • Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
    Xiaoning He, Lizheng Shi, Jing Wu
    Current Medical Research and Opinion.2018; 34(6): 1089.     CrossRef
  • Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population
    Shijia Wang, Yue Zhang, Min Chen, Yong Wang, Yifei Feng, Ziwei Xu, Dongsheng Zhang, Yueming Sun, Zan Fu
    Oncotarget.2018; 9(42): 26616.     CrossRef
  • Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD)
    Prateek Sharma, Sanjeev Kumar
    Cellular Oncology.2018; 41(6): 637.     CrossRef
  • 3. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Medical Care in Diabetes—2018

    Diabetes Care.2018; 41(Supplement): S28.     CrossRef
  • 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
    Nieves González, Isabel Prieto, Laura del Puerto-Nevado, Sergio Portal-Nuñez, Juan Antonio Ardura, Marta Corton, Beatriz Fernández-Fernández, Oscar Aguilera, Carmen Gomez-Guerrero, Sebastián Mas, Juan Antonio Moreno, Marta Ruiz-Ortega, Ana Belen Sanz, Mar
    Oncotarget.2017; 8(11): 18456.     CrossRef
  • Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
    Enrico Capobianco
    Clinical and Translational Medicine.2017;[Epub]     CrossRef
  • Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway
    A Vasconcelos-dos-Santos, H F B R Loponte, N R Mantuano, I A Oliveira, I F de Paula, L K Teixeira, J C M de-Freitas-Junior, K C Gondim, N Heise, R Mohana-Borges, J A Morgado-Díaz, W B Dias, A R Todeschini
    Oncogenesis.2017; 6(3): e306.     CrossRef
  • A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes
    Zhihua Du, Vladimir Uversky
    International Journal of Molecular Sciences.2017; 18(10): 2010.     CrossRef
  • Colon cancer modulation by a diabetic environment: A single institutional experience
    Isabel Prieto, Laura del Puerto-Nevado, Nieves Gonzalez, Sergio Portal-Nuñez, Sandra Zazo, Marta Corton, Pablo Minguez, Carmen Gomez-Guerrero, Jose Miguel Arce, Ana Belen Sanz, Sebastian Mas, Oscar Aguilera, Gloria Alvarez-Llamas, Pedro Esbrit, Alberto Or
    PLOS ONE.2017; 12(3): e0172300.     CrossRef
  • Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database
    Marietta Stadler, Esther Bollow, Maria Fritsch, Wolfgang Kerner, Ingrid Schuetz‐Fuhrmann, Dietmar Krakow, Sigrun Merger, Michaela Riedl, Peter Jehle, Reinhard W. Holl
    Diabetes, Obesity and Metabolism.2017; 19(8): 1171.     CrossRef
  • Review of 2017 Diabetes Standards of Care
    Kate Crawford
    Nursing Clinics of North America.2017; 52(4): 621.     CrossRef
  • Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression
    Julio De-Freitas-Junior, Jéssica Andrade-da-Costa, Mariana Silva, Salomé Pinho
    International Journal of Molecular Sciences.2017; 18(9): 1921.     CrossRef
  • 3. Comprehensive Medical Evaluation and Assessment of Comorbidities

    Diabetes Care.2017; 40(Supplement): S25.     CrossRef
  • Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells
    Hao Cai, Yunhui Zhang, Tianxiang Kevin Han, Ruth S. Everett, Dhiren R. Thakker
    International Journal of Cancer.2016; 138(9): 2281.     CrossRef
  • Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism
    Elrashdy M. Redwan, Moustafa H. Linjawi, Vladimir N. Uversky
    Scientific Reports.2016;[Epub]     CrossRef
  • Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population
    Rui Sun, Jian-Ping Liu, Chang Gao, Ying-Ying Xiong, Min Li, Ya-Ping Wang, Yan-Wei Su, Mei Lin, An-Li Jiang, Ling-Fan Xiong, Yan Xie, Jue-Ping Feng
    Oncotarget.2016; 7(20): 29770.     CrossRef
  • 3. Foundations of Care and Comprehensive Medical Evaluation

    Diabetes Care.2016; 39(Supplement): S23.     CrossRef
  • Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
    Yu Mi Kang, Ye-Jee Kim, Joong-Yeol Park, Woo Je Lee, Chang Hee Jung
    Cardiovascular Diabetology.2016;[Epub]     CrossRef
  • Association Between Chronic Conditions and Physical Function Among Veteran and Non-Veteran Women With Diabetes
    Kristen E. Gray, Jodie G. Katon, Eileen Rillamas-Sun, Lori A. Bastian, Karin M. Nelson, Andrea Z. LaCroix, Gayle E. Reiber
    The Gerontologist.2016; 56(Suppl 1): S112.     CrossRef
  • 3. Initial Evaluation and Diabetes Management Planning

    Diabetes Care.2015; 38(Supplement): S17.     CrossRef
  • Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy
    Hyung‐yul Lee, Dan Wei, Mary R. Loeken
    Diabetes/Metabolism Research and Reviews.2014; 30(1): 23.     CrossRef
  • Standards of Medical Care in Diabetes—2014

    Diabetes Care.2014; 37(Supplement): S14.     CrossRef
  • Detection bias may be the main cause of increased cancer incidence among diabetics: Results from the Rotterdam Study
    Kirstin M.J. De Bruijn, Rikje Ruiter, Catherine E. de Keyser, Albert Hofman, Bruno H. Stricker, Casper H.J. van Eijck
    European Journal of Cancer.2014; 50(14): 2449.     CrossRef
  • Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6-Year Follow-up Study
    Hsiu-Chen Lin, Baxter H. Kachingwe, Hsiu-Li Lin, Hui Wen Cheng, Yow-Shieng Uang, Li-Hsuan Wang
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2014; 34(1): 36.     CrossRef
  • Hyperglycemia as a Risk Factor for Cancer Progression
    Tae Young Ryu, Jiyoung Park, Philipp E. Scherer
    Diabetes & Metabolism Journal.2014; 38(5): 330.     CrossRef
  • High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells
    Chanchal Gupta, Kulbhushan Tikoo
    Journal of Molecular Endocrinology.2013; 51(1): 119.     CrossRef
  • Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
    K M J De Bruijn, L R Arends, B E Hansen, S Leeflang, R Ruiter, C H J van Eijck
    British Journal of Surgery.2013; 100(11): 1421.     CrossRef
  • Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
    Xiao-Lei Wang, Cun-Xian Jia, Li-Yuan Liu, Qiang Zhang, Yu-Yang Li, Liang Li
    World Journal of Surgical Oncology.2013;[Epub]     CrossRef
  • Effect of Type 2 Diabetes Mellitus on Prognosis of Nonmetastatic Renal Cell Cancer
    Evren Süer, Erdem Öztürk, Ömer Gülpınar, Aytaç Kayış, Sümer Baltacı
    Korean Journal of Urology.2013; 54(8): 499.     CrossRef
  • Glycemic index, glycemic load and cancer risk
    J. Hu, C. La Vecchia, L.S. Augustin, E. Negri, M. de Groh, H. Morrison, L. Mery
    Annals of Oncology.2013; 24(1): 245.     CrossRef
  • The Relationship between Type 2 Diabetes and Cancer: An Integrative Review
    Mutaz Arafat Altamimi
    SSRN Electronic Journal.2013;[Epub]     CrossRef
  • Diabetes Mellitus and the Risk for Developing Cancer
    Shane Malachy Markey, Marie A Congiusta
    International Journal of Experimental Dental Science.2013; 2(1): 41.     CrossRef
  • Standards of Medical Care in Diabetes—2013

    Diabetes Care.2013; 36(Supplement): S11.     CrossRef
  • Targeted therapy in rare cancers—adopting the orphans
    Javier Munoz, Razelle Kurzrock
    Nature Reviews Clinical Oncology.2012; 9(11): 631.     CrossRef
  • Obesity and Pancreatic Diseases
    Ho Gak Kim, Jimin Han
    The Korean Journal of Gastroenterology.2012; 59(1): 35.     CrossRef
  • CYP2W1, CYP4F11 and CYP8A1 Polymorphisms and Interaction of CYP2W1 Genotypes with Risk Factors in Mexican Women with Breast Cancer
    N. Cardenas-Rodriguez, E. Lara-Padilla, C. Bandala, J. Lopez-Cruz, C. Uscanga-Carmona, P.F. Lucio-Monter, E. Floriano-Sanchez
    Asian Pacific Journal of Cancer Prevention.2012; 13(3): 837.     CrossRef
  • Standards of Medical Care in Diabetes—2012

    Diabetes Care.2012; 35(Supplement): S11.     CrossRef
  • The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
    Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2012; 36(5): 371.     CrossRef
  • L’uso prolungato di metformina è associato con la riduzione del rischio di carcinoma mammario
    M. Bodmer, C. Meier, S. Krähenbühl, S. S. Jick, C. R. Meier, Francesca Marciello, Antongiulio Faggiano, Annamaria Colao
    L'Endocrinologo.2011; 12(6): 310.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP